ࡱ> @B;<=>? nnbjbj ڌ;f2 8333###ؓz#!N###33####33####%T45Y30Xo#"YV<}0VJ#"Jx5Y5Y0JeY8################J######### : Sample Opioid Treatment Agreements Some experts in pain management, as well as various guidelines and reference sources, recommend that patients prescribed long-term opioid therapy should read and sign an Opioid Treatment Agreement. This specifies patient obligations and responsibilities, along with prescriber policies, such as those regarding confidentiality, prescription refills, urine drug monitoring, etc. Currently, there is no standardized or universally accepted Opioid Treatment Agreement [as of August 2010]. The various Agreement documents on the following pages of this text document are examples that can be readily customized to suit the individual needs of opioid prescribers for clinical use with their patients. Document / SourcePage(s)Opioid Treatment Agreement Adapted from: VA/DoD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain. Guideline Summary. Department of Veterans Affairs / Department of Defense. May 2010, ver 2.0. Accessed at: HYPERLINK "http://www.healthquality.va.gov/HEALTHQUALITY/cot/cot_310_sum.pdf" \t "_blank"http://www.healthquality.va.gov/HEALTHQUALITY/cot/cot_310_sum.pdf3Agreement for Opioid Maintenance Therapy for Non-Cancer/Cancer Pain From: PainEdu.com; courtesy of Howard A. Heit, MD, FACP, FASAM (undated). Accessed at: HYPERLINK "http://www.painedu.com/Downloads/AdditionalMaterials/Agreement_for_Opioid_Maintenance_Therapy_for_Non-Cancer_and_Cancer_Pain.pdf" \t "_blank"http://www.painedu.com/Downloads/AdditionalMaterials/Agreement_for_Opioid_Maintenance_Therapy_for_Non-Cancer_and_Cancer_Pain.pdf4-5Treatment Plan for Prescribing Opioids From: Utah Department of Health. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain. Salt Lake City, UT: Utah Department of Health. 2009. Accessed at:  HYPERLINK "http://health.utah.gov/prescription/pdf/guidelines/final.04.09opioidGuidlines.pdf" http://health.utah.gov/prescription/pdf/guidelines/final.04.09opioidGuidlines.pdf6-7Sample Model Pain Management Agreement From: American Academy of Pain Management. 1999. Accessed at: HYPERLINK "http://www.aapainmanage.org/literature/Articles/OpioidAgreements.pdf" \t "_blank"http://www.aapainmanage.org/literature/Articles/OpioidAgreements.pdf8Low Literacy Pain Medicine Agreement Adapted from: PainEdu.com; originally created by Lorraine S. Wallace, PhD (undated). Accessed at: HYPERLINK "http://www.painedu.com/Downloads/tools/LowLiteracyMedicationManagementContract.pdf" \t "_blank"http://www.painedu.com/Downloads/tools/LowLiteracyMedicationManagementContract.pdf9-11Inclusion of a particular Opioid Treatment Agreement in this document does not denote endorsement or recommendation for use by Opioids911-Safety. The Low Literacy Pain Medicine Agreement was validated in field testing; however, it may be overly simplistic and incomplete for many patients or clinical situations. The other documents are from credible sources but the required literacy level may be advanced for some patients. Also, in most cases the sample Agreements specify that the opioid prescriber is a physcian and may need modification in certain cases to indicate that another authorized healthcare provider (eg, PA, NP, PharmD) is the prescriber. There has been some controversy surrounding the advantages of Opioid Treatment Agreements (sometimes erroneously referred to as Contracts) due to a lack of research on their effectiveness in benefitting treatment outcomes, and there are some questions as to whether most patients fully comprehend their meaning and significance. This subject was discussed in an edition of the Pain Treatment Topics e-Briefing Newsletter (which can be accessed at: HYPERLINK "http://pain-topics.org/pdf/e-Briefing-Vol2-No2-2007.pdf" \t "_blank"http://pain-topics.org/pdf/e-Briefing-Vol2-No2-2007.pdf). Opioid Treatment Agreements do not substitute for patient education on opioid safety. A primary benefit of such Agreements may be in establishing a clear set of rules governing the relationship between prescriber and patient. Agreements are often especially recommended (or required) in patients at high risk for opioid medication abuse or having a history of substance abuse or psychiatric comorbidity. The Agreement does not necessarily replace an Informed Consent for Opioid Treatment, which spells out potential risks and hazards of opioid therapy (eg, adverse reactions, physical dependence, addiction, overdose, special instructions for use, and other cautions). Section 2E of the Opioids911-Safety patient/caregiver education program titled, What is an opioid treatment agreement? describes for patients and their caregivers Rules of the Road for using opioid medicines, including patient responsibilities that are generally a part of any formal Agreement. Patients are instructed that, even if they are not asked to sign an Agreement document, for their own safety and the protection of others they must be willing to follow the Rules that are listed. Researcher: Stewart B. Leavitt, MA, PhD Document Date: First publication September 2010 Disclaimer: The contents of Opioids911-Safety are not intended to offer medical advice and should not be used for diagnosing or treating particular health conditions.  Copyright 2010, Opioids911-Safety from  HYPERLINK "http://pain-topics.org/" \t "_blank" Pain Treatment Topics (SBL Ltd, Glenview, IL 60025). All rights reserved under a  HYPERLINK "http://creativecommons.org/licenses/by-nc/3.0/" \t "_blank" Creative Commons Attribution-NonCommercial 3.0 Unported License. Opioid Treatment Agreement I understand that my provider and I will work together to find the most appropriate treatment for my chronic pain. I understand the goals of treatment are not to eliminate pain, but to partially relieve my pain in order to improve my ability to function. Chronic opioid therapy is only ONE part of my overall pain management plan. I understand that my provider and I will continually evaluate the effect of opioids on achieving the treatment goals and make changes as needed. I agree to take the medication at the dose and frequency prescribed by my provider. I agree not to increase the dose of opioids on my own and understand that doing so may lead to the treatment with opioids being stopped. I understand that the common adverse effects of opioid therapy include constipation, nausea, sweating, and itchiness of the skin. Drowsiness may occur when starting opioid therapy or when increasing the dosage. I agree to refrain from driving a motor vehicle or operating dangerous machinery until such drowsiness disappears. I will not seek opioid medications from another physician for the treatment of my chronic pain. Regular follow-up care is required and only my provider will prescribe these medications for my chronic pain for me at scheduled appointments. I will attend all appointments, treatments, and consultations as requested by my providers. I will attend all pain appointments and follow pain management recommendations. I will not give or sell my medication to anyone else, including family members; nor will I accept any opioid medication from anyone else. I agree to be responsible for the secure storage of my medication at all times. If these medications are stolen, I will report this to police and my provider and will produce a police report of this event if requested to do so. I understand that if my prescription runs out early for any reason (for example, if I lose the medication or take more than prescribed), my provider may not prescribe extra medication for me. I may have to wait until the next prescription is due. I understand that the use of other medications can cause adverse effects or interfere with opioid therapy. Therefore, I agree to notify my provider of the use of all substances, including marijuana, alcohol, medications not prescribed for me (tranquilizers), and all illicit drugs. I agree to periodic unscheduled drug screens. I understand that I may become physically dependent on opioid medications, which in a small number of patients may lead to addiction. I agree that if necessary, I will permit referral to addiction specialists as a condition of my treatment plan. I understand that my failure to meet these requirements may result in my provider choosing to stop writing opioid prescriptions for me. Withdrawal from the medications will be coordinated by the provider and may require specialist referrals. I hereby agree that my provider has the authority to discuss my pain management with other health care professionals and my family members when it is deemed medically necessary in the providers judgment. My providers may obtain information from State controlled substances databases and other prescription monitoring programs. Signatures: ________________________________ ____________________________________ Agreement for Opioid Maintenance Therapy for Non-Cancer/Cancer Pain The purpose of this agreement is to give you information about the medications you will be taking for pain management and to assure that you and your physician comply with all state and federal regulations concerning the prescribing of controlled substances. A trial of opioid therapy can be considered for moderate to severe pain with the intent of reducing pain and increasing function. The physicians goal is for you to have the best quality of life possible given the reality of your clinical condition. The success of treatment depends on mutual trust and honesty in the physician/patient relationship and full agreement and understanding of the risks and benefits of using opioids to treat pain. You should use one physician to prescribe and monitor all opioid medications and adjunctive analgesics. You should use one pharmacy to obtain all opioid prescriptions and adjunctive analgesics prescribed by your physician. Pharmacy: __________________________ Phone number: _____________________ You should inform your physician of all medications you are taking, including herbal remedies, since opioid medications can interact with over-the-counter medications and other prescribed medications, especially cough syrup that contains alcohol, codeine or hydrocodone. You will be seen on a regular basis and given prescriptions for enough medication to last from appointment to appointment, plus usually two to three days extra. This extra medication is not to be used without the explicit permission of the prescribing physician unless an emergency requires your appointment to be deferred one or two days. Prescriptions for pain medicine or any other prescriptions will be done only during an office visit or during regular office hours. No refills of any medications will be done during the evening or on weekends. You must bring back all opioid medications and adjunctive medications prescribed by your physician in the original bottles. You are responsible for keeping your pain medication in a safe and secure place, such as a locked cabinet or safe. You are expected to protect your medications from loss or theft. Stolen medications should be reported to the police and to your physician immediately. If your medications are lost, misplaced or stolen, your physician may choose not to replace the medications or to taper and discontinue the medications. You may not give or sell your medications to any other person under any circumstances. If you do, you may endanger that persons health. It is also against the law. Any evidence of drug hoarding, acquisition of any opioid medication or adjunctive analgesia from other physicians (which includes emergency rooms), uncontrolled dose escalation or reduction, loss of prescriptions, or failure to follow the agreement may result in termination of the doctor/patient relationship. You will communicate fully to your physician to the best of your ability at the initial and all follow-up visits your pain level and functional activity along with any side effects of the medications. This information allows your physician to adjust your treatment plan accordingly. You should not use any illicit substances, such as cocaine, marijuana, etc. while taking these medications. This may result in a change to your treatment plan, including safe discontinuation of your opioid medications when applicable or complete termination of the doctor/patient relationship. The use of alcohol and opioid medications is contraindicated. You agree and understand that your physician reserves the right to perform random or unannounced urine drug testing. If requested to provide a urine sample, you agree to cooperate. If you decide not to provide a urine sample, you understand that your doctor may change your treatment plan, including safe discontinuation of your opioid medications when applicable or complete termination of the doctor/patient relationship. The presence of a non-prescribed drug(s) or illicit drug(s) in the urine can be grounds for termination of the doctor/patient relationship. Urine drug testing is not forensic testing, but is done for your benefit as a diagnostic tool and in accordance with certain legal and regulatory materials on the use of controlled substances to treat pain. There are side effects with opioid therapy, which may include, but not exclusively, skin rash, constipation, sexual dysfunction, sleeping abnormalities, sweating, edema, sedation, or the possibility of impaired cognitive (mental status) and/or motor ability. Overuse of opioids can cause decreased respiration (breathing). Physical dependence and/or tolerance can occur with the use of opioid medications. Physical dependence means that if the opioid medication is abruptly stopped or not taken as directed, a withdrawal syndrome can occur. This is a normal physiological response. The withdrawal syndrome could include, but not exclusively, sweating, nervousness, abdominal cramps, diarrhea, goose bumps, and alterations in ones mood. It should be noted that physical dependence does not equal addiction. One can be dependent on insulin to treat diabetes or dependent on prednisone (steroids) to treat asthma, but one is not addicted to the insulin or prednisone. Addiction is a primary, chronic neurobiologic disease with genetic, psychosocial and environmental factors influencing its development and manifestation. It is characterized by behavior that includes one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and cravings. This means the drug decreases ones quality of life. Tolerance means a state of adaptation in which exposure to the drug induces changes that result in diminution of one or more of the drugs effects over time. The dose of the opioid may have to be titrated up or down to a dose that produces maximum function and a realistic decrease of the patients pain. If you have a history of alcohol or drug misuse/addiction, you must notify the physician of such history since the treatment with opioids for pain may increase the possibility of relapse. A history of addiction does not, in most instances, disqualify one for opioid treatment of pain, but starting or continuing a program for recovery is a must. You agree to allow your physician to contact any health care professional, family member, pharmacy, legal authority, or regulatory agency to obtain or provide information about your care or actions if the physician feels it is necessary. You agree to a family conference or a conference with a close friend or significant other if the physician feels it is necessary. The above agreement has been explained to me by [INSERT PRESCRIBER NAME HERE]. I agree to its terms so that [INSERT PRESCRIBER NAME HERE] can provide quality pain management using opioid therapy to decrease my pain and increase my function. Patients Signature ___________________________________ Date__________________________ Witnesss Signature __________________________________ Date___________________________ Treatment Plan Using Prescription Opioids Patient name: _____________________________________________________________________ Prescriber name: __________________________________________________________________ The PUrPOse Of This agreemenT is TO sTrUcTUre OUr Plan TO wOrk TOgeTher TO TreaT yOUr chrOnic Pain. This will PrOTecT yOUr access TO cOnTrOlled sUbsTances and OUr abiliTy TO Prescribe Them TO yOU. I (patient) understand the following (initial each): _____ Opioids have been prescribed to me on a trial basis. One of the goals of this treatment is to improve my ability to perform various functions, including return to work. If significant demonstrable improvement in my functional capabilities does not result from this trial of treatment, my prescriber may determine to end the trial. Goal for improved function: _______________________________________________ _____ Opioids are being prescribed to make my pain tolerable but may not cause it to disappear entirely. If that goal is not reached, my physician may end the trial. Goal for reduction of pain: ________________________________________________ _____ Drowsiness and slowed reflexes can be a temporary side effect of opioids, especially during dosage adjustments. If I am experiencing drowsiness while taking opioids, I agree not to drive a vehicle or perform other tasks that could involve danger to myself or others. _____ Using opioids to treat chronic pain will result in the development of a physical dependence on this medication, and sudden decreases or discontinuation of the medication will lead to symptoms of opioid withdrawal. These symptoms can include: runny nose, yawning, large pupils, goose bumps, abdominal pain and cramping, diarrhea, vomiting, irritability, aches and flu-like symptoms. I understand that opioid withdrawal is uncomfortable but not physically life threatening. _____ There is a risk that opioid addiction can occur. Almost always, this occurs in patients with a personal or family history of other drug or alcohol abuse. If it appears that I may be developing addiction, my physician may determine to end the trial. I agree to the following (initial each): _____ I agree not to take more medication than prescribed and not to take doses more frequently than prescribed. _____ I agree to keep the prescribed medication in a safe and secure place, and that lost, damaged, or stolen medication will not be replaced. _____ I agree not to share, sell, or in any way provide my medication to any other person. _____ I agree to obtain prescription medication from one designated licensed pharmacist. I understand that my doctor may check a Controlled Substance Database or Prescription Monitoring Program at any time to check my compliance. _____ I agree not to seek or obtain any mood-modifying medication, including pain relievers or tranquilizers from any other prescriber without first discussing this with my prescriber. If a situation arises in which I have no alternative but to obtain my necessary prescription from another prescriber, I will advise that prescriber of this agreement. I will then immediately advise my prescriber that I obtained a prescription from another prescriber. _____ I agree to refrain from the use of all other mood-modifying drugs, including alcohol, unless agreed to by my prescriber. The moderate use of nicotine and caffeine are an exception to this restriction. _____ I agree to submit to random urine, blood or saliva testing, at my prescribers request, to verify compliance with this, and to be seen by an addiction specialist if requested. _____ I agree to attend and participate fully in any other assessments of pain treatment programs which may be recommended by the prescriber at any time. I understand that any deviation from the above agreement may be grounds for the prescriber to stop prescribing opioid therapy at any time. ________________________________________________________ _______________________ Patient Signature Date ________________________________________________________ _______________________ Prescriber Signature Date Produced by Utah Department of Health, Prescription Pain Medication Program, 2008 SAMPLE MODEL PAIN MANAGEMENT AGREEMENT The purpose of this Agreement is to prevent misunderstandings about certain medicines you will be taking for pain management. This is to help both you and your doctor to comply with the law regarding controlled pharmaceuticals. I understand that this Agreement is essential to the trust and confidence necessary in a doctor/patient relationship and that my doctor undertakes to treat me based on this Agreement. I understand that if I break this Agreement, my doctor will stop prescribing these pain-control medicines. In this case, my doctor will taper off the medicine over a period of several days, as necessary, to avoid withdrawal symptoms. Also, a drug-dependence treatment program may be recommended. I will communicate fully with my doctor about the character and intensity of my pain, the effect of the pain on my daily life, and how well the medicine is helping to relieve the pain. I will not use any illegal controlled substances, including marijuana, cocaine, etc. I will not share, sell or trade my medication with anyone. I will not attempt to obtain any controlled medicines, including opioid pain medicines, controlled stimulants, or antianxiety medicines from any other doctor. I will safeguard my pain medicine from loss or theft. Lost or stolen medicines will not be replaced. I agree that refills of my prescriptions for pain medicine will be made only at the time of an office visit or during regular office hours. No refills will be available during evenings or on weekends. I agree to use ____________________________________________Pharmacy, located at _______________________________________________________, telephone number _________________________, for filling prescriptions for all of my pain medicine. I authorize the doctor and my pharmacy to cooperate fully with any city, state or federal law enforcement agency, including this states Board of Pharmacy, in the investigation of any possible misuse, sale, or other diversion of my pain medicine. I authorize my doctor to provide a copy of this Agreement to my pharmacy. I agree to waive any applicable privilege or right of privacy or confidentiality with respect to these authorizations. I agree that I will submit to a blood or urine test if requested by my doctor to determine my compliance with my program of pain control medicine. I agree that I will use my medicine at a rate no greater than the prescribed rate and that use of my medicine at a greater rate will result in my being without medication for a period of time. I will bring all unused pain medicine to every office visit. I agree to follow these guidelines that have been fully explained to me. All of my questions and concerns regarding treatment have been adequately answered. A copy of this document has been given to me. This Agreement is entered into on this ____ day of _____________, ________ Patient signature: _________________________________________________ Physician signature: _______________________________________________ Witnessed by: ____________________________________________________ Pain Medicine Agreement This agreement has 4 parts. Part 1. Tells you how and when to take your pain medicine. Part 2. Lists things you agree to do. Part 3. What could happen if you do NOT do the things listed in Part 2. Part 4. Sign the form. You and [INSERT OPIOID PRESCRIBER NAME] must sign the form. PART 1. MY PAIN MEDICINE  PART 2. THINGS I AGREE TO DO I will only get my pain medicine from [OPIOID PRESCRIBERS] office. take my pain medicine as listed in Part 1. tell my other doctor(s) that I am taking pain medicine. tell [OPIOID PRESCRIBER] about ALL of the medicines (over-the-counter, herbs, vitamins, those ordered by other doctors) I am taking. tell [OPIOID PRESCRIBER] about all of my health problems. allow [OPIOID PRESCRIBER] to talk with other doctors about my health problems. only ask for refills during an office visit (Monday to Friday from 8:00 am to 5:00 pm). tell [OPIOID PRESCRIBER] if I get pain medicine from another doctor or emergency room. call [OPIOID PRESCRIBERS] office at least 24 hours in advance if I need to cancel my appointment. keep my pain medicine in a safe place AND away from children. get my pain medicine from only [INSERT PHARMACY NAME]. Address: __________________________ Phone Number: ____________________ bring all of my unused pain medicine in their pharmacy bottles the next time I come to see [OPIOID PRESCRIBER]. He/she may count the number of pills in my bottle(s). allow [OPIOID PRESCRIBER] to check my urine (pee) or blood to see what drugs I am taking. I will NOT share, sell or trade my pain medicine with anyone. use someone elses medicine(s). use illegal drugs (crystal meth, marijuana, cocaine). change how I take my medicine(s) without asking [OPIOID PRESCRIBER]. ask [OPIOID PRESCRIBER] for extra refills if I use up my supply before my next appointment. ask [OPIOID PRESCRIBER] for extra refills if I lose or misplace mine. PART 3. I UNDERSTAND If I do not do all of the things listed in Part 2, [OPIOID PRESCRIBER]: will no longer order pain medicine for me. may stop giving me medical care. may send me to drug abuse treatment. I know [OPIOID PRESCRIBER] and my pharmacy may work with the police to look at any misuse or sale of my pain medicine. If I drive while taking pain medicine, I can be charged with driving under the influence (DUI). If I am charged with DUI while taking pain medicine, [OPIOID PRESCRIBER] is not to blame. PART 4. SIGN THE FORM Sign your name and write the date. ______________________________ _________________ Sign your name Date __________________ __________________________ Print your first name Print your last name __________________________________________________ Street City State Zip Code _______________________ Opioid Prescriber Name _______________________ Opioid Prescriber Signature _______________________ Date      http://Opioids911.org  PAGE 1 "#$%}~1 3 ; < q r D Z g ˴{wqwmwmwqwimiwqwqw`W`KWKhx2 hw,mHnHuhAOmHnHuhw,mHnHuhAOh%QY hw,NHhw,jhw,UmHnHu,hhH5B* CJ OJQJ^JaJ ph&hC5B* CJ OJQJ^JaJ ph,hAOh>5B* CJ OJQJ^JaJ ph,hh>5B* CJ OJQJ^JaJ ph9jhh]mB* CJ OJQJUaJ mHnHphu$ $$d(($5$7$8$9DH$Ifa$gdRl dgdAO $ ` a$gdEr$a$gde$dxa$gdg l s {  ? titZOhRh2CJaJjhRh|GCJUaJhRhZCJaJhRh|GCJaJ hRh|G5B* CJaJph hRh|G5B*CJaJphhRhdF5B*phhRh|G5B*phhAOhAOCJaJh%QYmHnHuh *mHnHuhemHnHuh# mHnHuhx2 hw,mHnHuhw,mHnHu b@!dPP$5$7$8$9DH$IfgdRl kd$$IfTl0b!B%x!  t%GT%GT0%344 lap%GT%GTytRT? @ A  ! " # =>?BDjk̷|j\KD hy!hy! hRhy!5B* CJaJphhRh0J>*CJaJ#jhRho%CJUaJhRh2CJaJjhRhCJUaJhRhZCJaJhRh*BCJaJhRhCJaJ hRh5B* CJaJphh:+h|GhRh|G0J>*CJaJjhRh|GCJUaJ#jhRho%CJUaJ =kd$$IfTl0b!B%x!  t0%344 lapytRT$$dPP$5$7$8$9DH$Ifa$gdRl  ?C$$dPP$5$7$8$9DH$Ifa$gdRl !dPP$5$7$8$9DH$IfgdRl CDb@!dPP$5$7$8$9DH$IfgdRl kd`$$IfTl0b!B%x!  t0%344 lapytRTkquvw4ǰ}vrn]QFhRh[CJaJhRh[5CJaJ hRh[5B* CJaJphh(h%QY hy!h(hRhy!0J>*CJaJ#j2hRhy!CJUaJ$hRhy!0J>*B*CJaJph-jhRhy!0J>*B*CJUaJphhRhy!CJaJhRh(CJNHaJhRhy!CJaJhRh(CJaJhRheCJaJ=kd$$IfTl0b!B%x!  t0%344 lapytRT$$dPP$5$7$8$9DH$Ifa$gdRl 45 Ucd𺶲uuj[I[#j hRho%CJUaJjhRh|GCJUaJhRhZCJaJhRh tCJaJhRh|GB* CJaJph hRh|G5B* CJaJph#hRh|G56B* CJaJphh|Gh%QYhRh|GCJaJhRh[0J>*CJaJ#jhRho%CJUaJhRh2CJaJjhRh[CJUaJ$$dPP$5$7$8$9DH$Ifa$gdRl !dPP$5$7$8$9DH$IfgdRl $b@!dPP$5$7$8$9DH$IfgdRl kd$$IfTl0b!B%x!  t0%344 lapytRT"#$%(*78DU_goy,;IPZ"ͻͲwĻwwnwwhZ9mHnHuh*BmHnHuhxJmHnHuhemHnHuhmHnHuhhr6mHnHuhspmHnHuhrmHnHuhmHnHuh TmHnHuhAOmHnHuh%QYh:+h|GjhRh|GCJUaJhRh|G0J>*CJaJ'$)* =1% $ ` a$gdEr $ ` a$gdxJkd $$IfTl0b!B%x!  t0%344 lapytRT$$dPP$5$7$8$9DH$Ifa$gdRl "7LMWdj|}~  acs{DK#&,4{ri`rW`r`N`N`hmHnHuhrmHnHuhAOmHnHuhCmHnHuhZ9mHnHuh2h*BmHnHuh2h20J>*mHnHu&j h2ho%UmHnHuh2h2mHnHu jh2h2UmHnHuh:+mHnHuh TmHnHuhhMi5mHnHuhChMi6mHnHuhMimHnHu4w"#/Q$-"hS)hh@*B*CJOJQJ^JaJph%GS-hh@*0JB*CJOJQJ^JaJph%GS*h~E0J5B*CJOJQJ^JaJph%GS0h~Eh~E0J5B*CJOJQJ^JaJph%GSh_IgmHnHuh]mmHnHuhZ9mHnHuhspmHnHuho%mHnHuhxJmHnHuhmHnHuh:+mHnHuhAOmHnHu F !"#%%'B'8(*)) & FdPPgd2^ $dPa$gdR4dgd d(gdd($dNgdEr $ ` a$gdEr")RuU?*)hJhJB*CJOJQJ^JaJph%GS*hErh@*0J6>*CJOJQJ^JaJ>j hErh_Ig6B*CJOJQJU]^JaJph%GS0hErhJ0J6B*CJOJQJ^JaJph%GS9jhErhJ0J6B*CJOJQJU^JaJph%GS)hJh@*B*CJOJQJ^JaJph%GS(jhJh~ECJUaJmHnHu)hh@*B*CJOJQJ^JaJph%GS)hhJB*CJOJQJ^JaJph%GS RSTgӾӪpYBY1 hehCJOJQJ^JaJ,hfhe5B* CJ OJQJ^JaJ ph,hfh5B* CJ OJQJ^JaJ phhH5CJOJQJ^JaJ)hJh@*B*CJOJQJ^JaJph%GS+hErh@*0J>*CJNHOJQJ^JaJ'hErh@*0J>*CJOJQJ^JaJ)hErh@*B*CJOJQJ^JaJph%GS2jhErh@*B*CJOJQJU^JaJph%GS#hJB*CJOJQJ^JaJph%GSgh ! i j !!!!!!!!]"^"a"b"""M#N#[#\#$$[$\$q$r$$$t%u%%%_&`&d&e&&&&&''(((((( ) )))W*X*\*]*q*r*޺ hehH2CJOJQJ^JaJ$hehCJNHOJQJ^JaJ hehCJOJQJ^JaJ heheCJOJQJ^JaJE)r*s**+-6..0]1022R44/6K7r88; & FdPPgd' & FdPPgdZN dPPgd' $Pa$gdf dPPgde & FdPPgd2^r*s*}*~****+++----../.5.6......00h0i0\1]1(2)2/2022233<4=4Q4ᷠ|||n||||h?>4CJOJQJ^JaJ$h'h'CJNHOJQJ^JaJ h'h'CJOJQJ^JaJ,hfh{>5B* CJ OJQJ^JaJ phh'CJOJQJ^JaJhbCJOJQJ^JaJhfCJOJQJ^JaJ hehCJOJQJ^JaJhZNCJOJQJ^JaJ'Q4R444[5\5$6%677J7K777q8r888=:>:y;z;;;<<<<<<<<J=K=^=====>>>>#?$?z?{????@@@@@AA B!BhDh.CJOJQJ^JaJ#h?>4h'5CJOJQJ^JaJh?>4CJOJQJ^JaJ$h'h'CJNHOJQJ^JaJ h'h'CJOJQJ^JaJhCJOJQJ^JaJ;;<K={?@!B{CiDDE3FFF G^G dPgdn dPPgd($dPPa$gd dxPgd?>4 dPPgdo%dPP^gd?>4 & FdPPgd' & FdPPgdo%hDiDDDDDE7E8E9EXEsEEEFF2F3FeFiFFFFFF򼥼yyyk]H)hh(B* CJ OJQJ^JaJ phh(CJOJQJ^JaJhNCJOJQJ^JaJh?>4CJOJQJ^JaJh?>46CJOJQJ^JaJhf6CJOJQJ^JaJ,h+?&h'6B*CJOJQJ^JaJph#h+?&h'6CJOJQJ^JaJ$h'h'CJNHOJQJ^JaJ h'h'CJOJQJ^JaJho%CJOJQJ^JaJFGG^GGGGG#H$HXHHHHHII?I@IIIUJVJmJnJJJ͹͓ͥnn`nRDhJCJOJQJ^JaJhCJOJQJ^JaJh,CJOJQJ^JaJ$h(h(CJNHOJQJ^JaJ#hJh(5CJOJQJ^JaJ#hJhn5CJOJQJ^JaJ&hnhn5;CJOJQJ^JaJ&hnh5;CJOJQJ^JaJ&hnh(5;CJOJQJ^JaJhnCJOJQJ^JaJ h(h(CJOJQJ^JaJ^G#HXHIIJJKMNNpOmmma dPgdJ0dPP^`0gd):0dPP^`0gddPP^`gd,0dPP^`0gdn dPgdn5dPP$d%d&d'dNOPQ]^gdn J]K^KKKnLoLLLLL=M>MMMMM>N?NNNONNNNNNNOOPPPPPPPQQQQQQQ-R.ReRfRRRRRhNCJOJQJ^JaJhJCJOJQJ^JaJ#hJh(5CJOJQJ^JaJ#hJh):5CJOJQJ^JaJh(CJOJQJ^JaJ$h(h(CJNHOJQJ^JaJh):CJOJQJ^JaJ h(h(CJOJQJ^JaJ2pOOZP@QSST$UUV"VwVVVVVWWXdgd^?^^^^^/_0_r_s_____````#auaǺǺǺǺǨ#h*B*phhN>*B*phh` hH5\hhAhH5B* \phhhAhGu5B* \ph h`hGuh`hGu5\ h`5\wcccc8d9dSdUdVdtd|dddeee/fffCggggd Lxgd LgdGu$a$gdpgd Lgdp xx^gdMQ  xx^ gdHRdSdTdUdVdWd^d_dhdsdtdzd{d|ddddddddddddҽ|n|j_WjSMF h mh m hGuNHhNhNB*phhTBh{>B*phh{>hMQ5B*CJ aJ ph hMQhGu5B*CJ aJ ph hhAhGu5B* CJ$aJ$phhf5B* CJ$aJ$ph hhAhMQ5B* CJ$aJ$ph)jhhAh mB* UmHnHphuhGuhMQB*CJ aJ phhGuj hGuhpUhhAhGuB* CJ$aJ$phdd#e$e5e6e@eAeeeeeeeeeeeee#f$f-f.f/f0frfsffffffffffffff2g3gzg{gggggƋч hGuNHhbhbB*phjh'8{UmHnHuhGuCJ aJ hV3jh LUmHnHu h'8{h'8{h LhTBhTBB*phhTB h Lh m hV3hV3 hMQh{>h{>hGujh mUmHnHu0ggggggggghh\h]hnhohhhhhii i i iiiiiiiiii署益xgYR h h jh UmHnHu hyhy5B*CJ aJ ph#h)]*hGu5>*B*CJ aJ ph h)]*hGu5B*CJ aJ phhTBB*CJ aJ phhTBhTBB*phh h{>B*phh{>h mB*CJ aJ phhGuB*CJ aJ phjh LUmHnHuhGuhTBh'8{B*phhNB*ph gghhiiiBibiii:jjjj k,kQkYkkllhxgdhA & F dxxgdk}  & F xgdy^gdyxgd)]*gdGugd L^gd'8{iiii>j?jPjQjjjjjjjjjjjjjj k kPkQkWkνΞ|qbqSEAh)]*jhk}UmHnHuh)]*hGuB*CJ aJ phh)]*h)]*B*CJ aJ phh)]*h)]*CJ aJ hmh)]*5B*CJ aJ ph hmhGu5B*CJ aJ ph hhAh)]*5B* CJ$aJ$phhf5B* CJ$aJ$ph hhAhTB5B* CJ$aJ$ph hhAhGu5B* CJ$aJ$phhk}5B*CJ$aJ$phhGuhTBhTBB*phhTBWkXkYkZkkklkkkkkkkkkk l l`lalrlsllllllָuָdSdB h mhGu5B*CJ aJ ph hhAh)]*5B* CJ$aJ$ph hhAhGu5B* CJ$aJ$phhNB*CJaJphjhk}UmHnHuhmB*CJaJphh B*CJaJph!hmhGuB*CJNHaJphhmhGuB*CJaJphhmhmB*CJaJphhmhmCJaJ hmh)]*5B*CJ aJ phhN5B*CJ aJ phlll mn@nAnCnDnFnGnknlnmnnn  !$gdb'gdk}gdGugd mxgd mlllllllmmmmm!mQmSmmmmmmmmmnn6n;nn?nAnBnDnEnGnHnInJnQn_n`nan|0jhs hy0J5CJOJQJU^JaJhyCJOJQJ^JaJ hb'hyCJOJQJ^JaJhyj`&hyUhRjhRUhk}hGuB*CJ aJ phhmB*CJ aJ phhfB*CJ aJ phhGuB*CJ aJ ph)angnhninjnknlnmnnnһҮhk}hGuB*CJ aJ phhRhyhb'hyOJQJ^J,hz0J5CJOJQJ^JaJmHnHu0jhs hy0J5CJOJQJU^JaJ'hs hy0J5CJOJQJ^JaJ21h:p L/ =!"#$% nRVۑR 0éxPNG  IHDRB~ PLTEw Tgr$FTڡh{foxER8D᫴ʷĶQ\dJOWԪʝƫ$)١ˣ喣䤧ꛟw^n\pe_.p f"EV&Uwq](~ H8p΀ve| S3 ozw@qϠ+6%5_ƌĚ{U)#MQ_on/uu%/xS~7|{[9oُċ..Jb 8;Zo*>otk Qhk \\nM(/@+rH9ݶ_}%U,#_!kW zOSF6ɖ Nfⵓ%s,W-j{kPbc#@D,Q||YFLx|JͦrCe{Ѓ/m[Y$i#G# tS{i-JZ;h)^?Q>ˈ{)G5IrzL]z jUrneʑzf0irxs}D^#+Հ]5?̊h= kiDYƉwFu:~\f=q$%)l8%n)^zPA򚅣UCsVj8=ZF5Uz?̈ n|/Ō[㮲86p~VpxDѕi>F;^FDYm;XC^nUi΃;ip8|\p iě}xK!<ᥧquC-y&36 71wjҒ3)^,݈ BIaĥB6gkX(+c,X%X˦`©L 2㞙!\䍲T@ecYXF <-{HgOXGr0ыV'zoi1ݳlC3\o&Pޯ#Hɬ ^8AXx  XuH\Z7Nb=x$#o~̒#f'1lZG=c;l{'C>g3 jDYcH-$ӳnn&I@$1bƌP]Ԏf =֎ ,#Heu}r  t -[8ȅe@30L~Ҫ;ˡR'=:7S6J@0P+1M.HYL_eE7|x~WAEn,uV&,'{]*G7(hmL% \YIxt^$`wF=`eq_H?#"?yߓ?f(s/f&xg V^uށݠXyc1@{5dXxc` `w^^vx2`7Bco8PuȱCm{<,aqlijyLvb.|Ԋy X^ t"j0(&OUz^{ECXa[=VUy|fh=ƤD%%xYd1okzUUz;x!&6}Ӣ3:XXl$b_.`;<*xNFfxrf 5Uv&HaOP0v Mu^-l 1{ρILۿV}J'V.ei A2j~i wL 䞟˿(;V9t G^3;9?Em9lglz5v4lf?RXq&xٴ Cyaz ]37c׎LGN  G6E|X.;#vduq8-C'!b5xϛϰX# ca7 $ '='':Tf;yt dKEm| ߑ ۩DŽUBؤ8?s/Xg{TU8|d|-|'0pAhs~~hL֨n {ŵɍF"ff^ku+x|>$.s*1_ ևy9C JcdCiw>=pXS[?$hh)( Xp,q$ pwN>t-[פVcTѹ "p_A-B QޚӎvIX_"V#*?CHk R 5OkY!knR DkV@c`̫ͅo ќKj68{qV& %0z#94&g _7p:h-K{ؐ@]_3/hy?E$[&h옩lj: ã5'xm ?[0^0$C#j ]X$ʃg <0>N-7[98ܡb UVJ+aK&;Ɂavx?栌r7@C] ;Bb9CV((_š?6,FT .gycG;+{ ᆰNj=Po81tƎ4+&PELɊVC1orkz#gK* rp!)5s9edYVIv9 zhDS;&r(gq|/K.^љ9FP dC?L1F\烵h`L=65=aa"czNH]Ec:E˒N(ITfɸ\-ħ_ Z֙b[`)E)c}0h0;.(xk Pk:nRK\lua /6Xa3AAӃ{upAp@KH ~<|==Or`'E kd ʓ'q7'Y&%Ux#0=9KFpa򌋐?uL4 o/HcnD4}xhɛ' ~(N6x|HcuNj`M2ٯ*LY,y6Xi.e_f  쉔NUJe 0qX14/WtYkFRDs៣#D0$ E fbexK|璭$@E{a4YgaRG N&Wzh>`cgFˍY7|oŅ:G[fFOt@V"HY(+ސW9a;.? O/IMc I;7p4;Mp )-k`m0eIh8 w7Me .:Il$w Fd[jNp/I?/'aE s<ы,,II݅ Z~ēFq W ;AAgw,qdGŰbm<ANz9E&RGN{ ng]̻=&b̒0lLf^s]9JYhD8<FkϤmZiHeml_82yL ۮ9K)$P'J/i`3/ lhOa<<;o=)k^N~ ^(; 8#U=xd6@:m4C.TXa҈I/\=)WVbYq]f{;d'6 K36l/Vِ:0?s(H K;y} W]#eBLO|$`<oo^3JV%%MMn ?|5LM5!>}sB `EJVUj hOmŽ5xEp2Pqo-yH/fK^ȼm6 ^ ^Qf Qa+82b@C7)Л.-!,a{RFx-2c .x; `h~_yූ( )oy$]X=l)筘wi m-;fO XQB;( @k>-Quybd:B;,hF=wj(J3a^ 'o жp>iT.g%gӸ1ZQaRmˡ6xj`w99^\ӑRp }|h^^ϋ4 6\^ [~ߞ"Q/ a.϶gdxۊd};gעYd|(lX?CCc FyZ-4{E #PiU KabV ޒ0$ȓU)Z8SE^a-,\kBcv3>++x^*LdGiCNm0}v?%iTCQ|%a/+nh;M. L'x+b6?4^O07?$lNUE xhg fu4]=Ť |lY!m%~9.mmwdSlo@(x~ށ)پb9-C;}=!lR xߟNl ST&5ώssw![[6:y_i i".Nn1meyTFp=5ׅ}mSS_JNM2![0< IVz\eN2ٮe\국-qA L'xnܶ7 k@Ta007U# I$ 0%54Kt4Ub_!yYVh6#6ww~;NĿqwk!ܾ`.oW/JfM[hЖxwNE Yk|ۚݡF;xscB <`y88!8.uTt7q{*bϾ ZK\T%:_sxZ-aa~\> *nMpHRC8q21 V7ҹwEN5sW 5Mp­u1DAҎ\;YV,G'x q@{pA*-\|r[7E`!3qZ-/x6Δ:F/vsѥ@S6si[V JeqUhM+ D7ub2|s!!x<LB B㐏wU/ N%w=[B φ&a]Ǣ:/r̊q 3/R '>xk|gڇ[4=)/C (?=: m 'DgVpn:-dnomfuݬpTeb0^ZSq>$e~-fp]/kh$3&rdžɮ*U[BJH?jl>LF2@` ^0ȷ6 Gg%ad$).K˨x)=^%dPCH, yu3fu޲!bRx!@*7;03>.*j]o-QF%x(H_zn SX9Jfa{B< :&.}R_GvhN>ֳdV݈v #d޻cR@;aC g oqlxOB *K$;t`մ#g}t|]pfIk ޻5-'tw<U3SזFdݠ^"pM<ߊ)|SD8Ps .Amp'x&~$ <;^[ωL&/2 n.֘ Z0GE ENyiڭW%a',:8 FO8{<;LHFܣ)o+[QhZ1 ""Ϝc;^'X~`ʙ7SAiiDw @ժ7ZZ !KmڜTxk[LJ1RXpx"ۢ?ʜgU*8}&}h%ŹVe17p "}\p@*7ڃѼA2߁wLjKM:I̹`# a7۸2/f +Q{V|,W*xapܥ*Ad WS\j޻[!%s*F+97΋`eEsQڋ- (HjϞ=uAhi5&^k`#d&,e :4YeAZz坋᜴D3PN|J1gN Nm^b*[ůl^Y9t3Һ^Pƻ{/E%=.& oU)|D>q,YEV~[õK^'4ҳü osi~/ލ4Vƈ 7y^Mdx90c%J`ڱ 2GX}\:Ӂwp8--5ŵ$ N E^*Hat Ky g"C߾BiX;3y]N\*!#_|t>q%Nkf[9yV`kGRwl*8|{at'0y]Q6ڸ߭UW$o>(23llZ0e cɖ"Kf"JK򽹍" '_YABv?"8n|C0 %yA1Ffg>G+\ݫaUX=qPS֘NM_"23²z%TR&OSvfi Y?> .|ʨ#8"q;HU.$gPwڷ1&Ň`ǦYnbx`bDjULGru1"rH2񻝋Y;k#T _ڡ{ xEgϸD6fKk`Cz<WDSR㊗>ЫVM1¼r,s4Kj1RNhE=R%QLv{y2J>}6KX P(2Lj;˿nĪ F"N SoHUx ^x&c>G*O%}Sم{ٳcC}NfGFJHY_2}Ց{Bf,Ԣt?鏝PUS(6sFǗUӧO?j|L/u3hOiv}HڧfEwȽ帮ʞDIou2J7Fk8,q\#Fj[ T:/AwꀾP#zjDUv}.I,LkK1ihsQa3E쬫qa9$0$kk/3yZ2fW]l;0+6xC} aH [JrU ٴFFx'' aean\TKkA_H>\`y%$p?~DX\&}>l G(*"3GeA!Nٸ>|ቷYRNƆ*%S M/EW&PSA)Adg7MtJKIy x!zƼk@A[*T9u Z^pPZȒ^(vh!ըysge5ԧOקUhkbj.Z J( yxCJrj^J}=eBQ"?e g4mʼ/%$$: (ȡ)$VD=yךՄ$R?H ScLX$TZ݌BeQ6CK߼bԬ6Ȭj飤H6-PoC7 n~/7o Э}!ߛ`7oW|#|wqqcڻ M!yQiP;%DDV"0 fzDqI&vtrlZ"7Qv#:wSX#,153 kZ0o&^yϞZ 󥞄\\23bVa$I>I ?&pוD(鼒N\%|KDNhD )h*yD*L^} L7n/m(sW䌾 DH{ PŨg!^. :-үOV;b Zak#{/CurgZ|?Edn v7)MChW_ohw%?>g& R|H8ᴗWI=*B>H4 ϼ4@a?x`L^x?&~Ygp_;oFބ:P,3 ^}9{ h4h~: Tb6~PjDKP@<6ɫPdsF&~R{NQ'+Sp)VI*u&M-y1%Bn|K^D:><te)݇[?='>ͫOЮ'dVz>Մ"E$ * b8O<՗0KnHgRv61#=LzI`FЂDhfy)7+hѷ+PIƼTxi/B F4,yGyUϕ[>[%wֿ .`w7Gi-fx#fJTK6?b5%}aQ_CGJMB~UC %` A,^ SNhlO R[Y"!GaÂm3 F皞iR67J6E}fUK Ƽˉ=n.%EX8nP -8CҨsO :/X2ꇟg}8 P7q9-X.%2C-,JAyA[V`콿z1ڰB&xƵD祚 ymKqP}-5Nh3%kN;>JC+eO9t _m0 %fjqj+\ŒDyJz<[Z QE'+&(xTjL{4b'CQ:35@^ܤ[ *TC"ݼg2/$)*6Yq pD#I}Ue>xO޳wjm t4Z?`^x5H-67d8yf'z^L&CA畫}tqoReJJ2%Hk0/YX|D0- 6ojƼT`jy`l 4z,+I VO{x٥m~pU{PEU-?/ICo$,}Jkhn< v\y?>= Ř˨jZ`*kҋ >It*Nk$K=#Q/U` c^9=ƼTx9;rsNcޏ"xe.`gvKm3}kzN'~TX12zyiXD yy/@G`hJA(NA+% (^ enRuٗw[2/KLJ;KxFA>WsHYr&>%N7EUH@fik!yPQ4@2R¦w(C6hMdhya#p4Kv8;My'ٰ6Pcq(&0b?yeƼͅC(dg ș6l2-T Q uWEɖfpJk8kBģs4 ֙}(7qX% yR(2&dLGQ 7D`^b~-2r3/kJվ|SڲỊB%83}uqf&ab,SU ?m o~[mۤjƽ>ڰW Na*VA}`W)Oc4u^u9EoS{~O_J21H`|L0o__lRi[yЇsN ՌӇU}s@ue1Nd^A%Mn6%^Τ72l8j FYlyB*Me$0+LLm f{G//%f }X#VT;l(N+D%{f"Qm=zDr;lľ{_d/9A.rdY|FW/ q=`# \E'3R05^89"9pIPW;ZfLzH,UFX)y ;NabeؐZ-a#9NtW,u`B),[:,&"= K"c1T1cN"$)=fv^J~:L`1眬@ 'O63?Tl6(tt%Ԭ*K-6M*ߠ-Đ$BUG Ť/zp{_ٔj F`|W_>]M))lվ[K))!Tȁf/ܣ)J K ɚlWTCSA5C!飄1ÆQ:l*,4)i+$v 2(2mC>*rl?ߩ{SBQ6|yytb`!?IN3 *i9!j"6U\6)D="MA&M*oꦕkۮeY퀗T6TR~* !]lEĽE:u0 DD:'Q1bj4DM: .3׆&0II+4!~)R.ORќPfD=kXgC}FhT7pg/ar`/3$ 4B6Ԑ!6#Zڶ\DVł R^jH YZ~XTWI߫^2&.sHh'Vs z4| z8np'C#귏%}Ԕ[[?EoêBeWE꾢<3z1xE`Yaɰeu4}i!t ^_=*r=+\=#M 鹗nR7a!~"lEm2z'$cpoԳWeR>&cs%h4z:͑OMY_WˀP p>w\Ft) )k0>3tU C#}ѝӦfFx˯3xx-[׻ UTlכBT6x @J۩y9tI!H5LOvT7Min/9|GH 2M#@5Xi&hK ēei^h_Wp$ {b$@YXZ32ptd3m'Of*]3 x{me&oӭL-L.0D@ˁaob#-)Pq xwkATtIޥD wP5jȸ8ۉLu^/v_%!GKd6COJkv/لzC!z{o>6[(xi 'to*i+\H*@: &FzAClwՆpcjC9)P'W?Ȥ9¢~N@ ^)1>ϛ]ѭ{K6,ؾ#@+XѪλOc0˄awCy;ȿc|&5}17sڀ#LZ8mW6Ϛ2^E eɃXQ69,A 'z®D$YrxFܾ]S/X@%)ߦ6˚K ]|Nbg2'˻.x;n% :m8j&%ې0|Qgh7 Z&Ju3#;+ԍne]~[F[2 %z_ÈԆ *Y î$Q«(UhLwlKL-7MOF`3vݧto3qҳ{wr՝|F4K.^RpdoK75.rvq T[e)6]yIb ?uMJ˼uϕ/@_ n?W] MJ ?Wҿ@]~I\ XIENDB`nk KM$n\.f#yPNG  IHDRW_tEXtSoftwareAdobe ImageReadyqe<fiTXtXML:com.adobe.xmp yPLTE½cdbkkk\\[BCBsrs444񥫤+++KKKfifޱRRRə<<C9{ƹw:=D%MB8Y@_K1mVmFfy3‛LjXU#祾scMul#uQQOng}qF |O}0rn—fA.p YcS%j9ҺCh0-I&ӏuprdO*4]Yh^;=Y6G9 :a)#ӜGiF(tg=^xWbL!&^4fUiMVXF~I!Ն*ٷ Q*}MU:^j!qځI45b^,lhxئEE.`,MrB(lCjh\_=k;RMJJ2B+|D]ڕ2D=BNiSYQExTnAgڣe8QUFj%YEebkvL~WfhWE\mʲ%Yp6vG9-$O78S{Q1eՈٻ*91[a<`]g[aeu x6j/te.r`+9Vy4ES3*B ̚7 ۡZf !%itSCZCNm1,SB8Ն*H N@OiD& 2|E~V<#Z峧lj@Iȴ hb"UFii rr3Z&nOD)'`uvL0@r:E{p6,;l ^p>TvZkHF#wD*p9Id*8xTLNk>};1AZ:yf9ằN\W8yc"s*S83a4\9B+h ZJ INݙcSP~ceF%] NPŢ1(nlY \@ ,p<@񆪁Ӓ̏u:bf0|\"GGj#th~+B tbz$Mw ,yQ,xQZNs-ʴ _mE(KzʔԃDbXkS{EK^,Uژ-kBK~ @+LZr%sd;N(\TDqʰ"+*cc+ܴSq b@y:$m.AC?@ݓc* 'fkxuoUWFq?O扸/;t|ϲ6 ߴ8_YE(*[D|r@]׉h>dIH8gτ5Y/0P5b,tGj5[7,O;y7yI+7 ).:9Z e,48!p$vbhBm:n"sa%ݯL} v?j34RK*N9/__/HPi:.umޱNaax7X]\sS+B|)p4~ ~Ѥ.;qTa%  t9 mYV^ʮܕiLbny.)7;',(Y] QPw'M9Me&@Omb_ulJT8a/k(:tLwmn\TI<:/2la4!)zvx%Z0@DṒʿ ^ܞ2JCsl{ v5Piz>/Ν]\&~4KӍzVwWg^^-~G<1C ِؗguU@|A(W"!RgwpIȹ #lD*%BG*$RwMۢrpB}M4eh]- ƩݜXa/x%܁:}u*>Hr_е2O+TFԧڒwڡ{6[*t g|0s)`0i=//2J;4PxYDtb* 5Q:WI!:wɖ n v4\(>%č˸ :̀4# !)Z`;z=۹GK\H\GXŸiHQ;eL.0cA:|(Pf#~e" QӸrtEimݖ ;dmj#kyn[Zuw{$Ed i/ho<7K*\V̤ 7@P\EG( TU8f?|U =).s il.wCehzL7U4(@ZnWqTx\J#3;jӭM&$RޗE"M፺=ަV~/-jAE7.g˥K.{;tp%i":}zTNr XW (8pEPee+J$ E\_WΘ &.Xdz}^9rowBXr9ۅ?^U]N@HerVv*hUJ7aa nv619v}V)Y^cB# cڬJ2hTL:nܸ{rWхkUmT-:]%toR5/ag|$-Zu?zCkVfʀi`NRhʘz,1";FQ/aq8v@T)OΦqI;_鬒NtE\otU*lӺ^^&ƈ"QսCm_l<|Tf/`q;=Q\j\4!/t%dn@Seb4/;*"Ieȟ{^TT:?D37yMEK-/3GLc088Q+,8qjGd"95*1Íka(IWgVYW6SM 4o?f6\Q$*-3z&UP!7[Yu#>>fiJ1 jc`ϜuiLh 2_nqR "2h76? {h9g@.Ux/Tv{ rIj%,+x>pL'Z)191MDVx甀qc࡟Js>9zWŵ?XwgټۜPY}7ͅ䬸!&^4 z./ ͍ƣ!*hCcF43 HKzFwJ@}4LҚrqaȁ[$^ƩO0 vDMCai s6[\5o0SPE7: V5G\L@wq/qnZjcMG;̵*>IU]gҶs_ƤN\k%^E?y\_{E*t1y cAb;'-esDgX^$LSFicD_뱊"|TT(_Jpԉ8;z=kh4^:,0aJE *~r}_qB9n(PtI WRg-WƔ0Ȯ`Yfڼ"SU;ˑ;: IU #X@zGz>lIb[s.j2o7ͤ,&\þ8[$?ڴmyb]Qp׵i8w_,|YzF_pHeP =.r E@o[\tXM%z8@\Ty>D( NA Vq?Z̷Xks.oÞI"]Xk>UX-*[[ cIYR%me(^s"e٪MxïsJY1 fxtƃ?yWf3ԧaӱQZ:X]dx-;|+1#s1%4x/rOsD(g0#+KiC-8v hy7eCEWWɩ|AhVFx%8F+ 91&GwX兆 WG{H (dvt>э`Hiګ)cv4b1'Eh8{㺫c')[ۡAj!iڸ4n*.dbܼ͓߇8YLZ7拕 *D\jb/.'20&:M:G'^2]V=8wƇǢ20|) C:#Zsw[I@`ʇ!ʜr@^p{ ے`)(WxCtW&W`P떧Lt8VX!ht3~ToDZ(I6 {OF}1  zH^BZEV̐.+V-ߛrlL{LEcioFjDC(v1˂ƕRh\sb#JEX< dܩu(+n`ʖ(Qz 9?ue\Y~Aɞ2`+4 )w='ƿ8sAe"8BiZrHJ->E0S?D Pi??:ϔ#gy<&I W>MF P5'( )hD9 hQħA@AiބGcZ r|~%%& EܹS]{AYmXաؓ"O16AOQ)TM#?N"Ҙy2Zgea<"w*bh;>[NY.rn3=,c\ L1oD&Gxv٧R[$v} bJ6w6nDer}} 2 ʅvhA&A?"΋쑮N p6AktYM`} -B RW,H6٭oi׾:Жf6TA{Nddp}`0¡ɠ4sv& +C@#Q@T oqL06 v0?%wVyFc Mu{̂i(mdD ;`!ȡ|,Wi f~,i0]tkj5'y0}й2Ce87mZQd2 ,Q#c ĀF 8͠+?@e ׉&d8mV5Yڶང `TiWB[AUh<pZAcLEHjj֑Hm) [9>@ >z<4i&`U`v$T[STƕzj{'C|"ׂEv Haq <ahlr%U}5-'c[6rku \1.aTaLׄ8,ѽ94 <+pBRJM;Rg koT)ǽ@}f6je.s)VR)T!2AX>[ >ыF(V# "#t 1Jl  pLa:PAūIJcoue8n27ܐ4֓E &F*x̹rTkD4098 Z"vTQ~J&)7-:h xחI;۟t;lfM%:F;mEWasSЂK'n|=3\[.y}C`u5oq a*2KT0|NA(A /i1Q @0}@t!0r@+γG@\[RD4vhE(! bCse8I鲄9k\1iT4P@^G1KzcAc\=mF)s,zmf"*4'~Z\ zEc<^mT@ݍ}ЕB+ 7;.`T*`FB0Qи(j\_ȟI>^,f쇋ĊyFg(sʵ,GEmkx(hF1(!@P*ӵSf1ԆL>%t?WRSҧ&2by#3 B -8 Ifa>ʱN/.(;8vIJRHN|Eq:J\弍 i GF_WTxOlc\1u)2)ۺ1!v yqN4M{RxeC+JSE8!EB"ԯࠠumqt{]jᄯ&U_M'] f< e?BM(~N?.vi|&fxZhȀS.(5ýcKFbt c%3,ӁJ[Ƒ '?Rƨ[vi_?)^7x_@8o0dB.|QF'e`>Q{Af.04S߉;8}vtlRFuQ`Һ/GE;@¡<'hC@b10B'gw `( eN 2,hnϝ >71VU%x>LWL) i փ<DOH҄Y#yS)=,<+Q?|UqlC֒_X-VMG4^-{pB jˍu^WyYx]`SEbi$H-CbihpZs?A"SҶwL7Az槩b=σqYЅ$!.X")J!L~%a= B 4ʠEo R‡(*zco{Nwgo|Ff 9A`}q#*:cV0XB|Mb*!Dub9CuFe"n}CN:s:Tp$%H1kʠeӴsV8 he|#"#XkVôM°0QH.VM2\VLҸZ,'6/U0lA(˽6( I Ps,)J beBM:)frI)uQJNh8~Sdxƒ/W=&roi)rZ(0baW 0$Uô4/,2! %0"Ц(Oy mq.eD]>xGǿlZ,zCCņZCn_ rGaY @$Oei爝H@ٖi/,(sڳ V5ƈkЎ!r[s NbU${Q7Aۻo1G Dž{EZ33qa-hs4n]Ét08_#Vt k ]@xd%C*C`XQY;ǔ9Mt}1B Hե1/gCQ1)[ƃ#@$E>kj/R7A4^>ܘ/>wf)g4f o&;~tc"W|H:XQdLOU<]+)ot P<zt٠ ʮCہ9<*O#XJf}+ܦک`%r|Kj7ՆYE'D f 6xy SUK<~ wYЎ7*^SQ *-Kd1m^$2(!A *\#3l 2@{v6<-D 紾?NAIM*:q|H  ж玿 9q2*vh^T\סOˣZfzae &`iB8Eq1:b]'>׭Y*w y-1'\I(5B!`,sfSE C>֭8"֏LוLɱ#~Ʒw `4ԣEA9d! x;c”1??l(J_jnǹi+LM'Hl 47OPVǪe20eO &DaTRP`I i&FԀ1^ I?qx k^IzA(TxS >ѹzD* /L=w.AzL)c|B䡹ġ<߁Q }9Z>☢VQN؋VLb7Vvۙ6쒴VE˄b[/a- o iw5=jzb2z:{魤ZI@L8ZDWrD\GNhI;Ɨ{z(hP&r~) {跹^qn畧(N0LJT>( Q<_*i^'7wwMGpocptr=-@ u4D/:aD~mYR  r P %JXgzS`ULm RitX4ɥP"pv$a΃Y'7Ni!8m"e&Ae6HY\MkA:6M*_IgjJ]i[HB -)ڂBs);@EY9Ёd)1 G h "½QSkCȞMvB@z}Sur:|k:X=P }.+1BjMLVgdmHFB|9Q_kJ3}~a=1DW4Zh 8PxG[Mǘv$mϟm,|v223PYzn;n6"KGxQ.YjI7i_^M6ѕ]#5 r~ v}4N~QMIrI:5[)3z !ucxϾg̈́vL\˯lj+jJq6VӪPց:2(`#oҘmz'1Ԟڤn ?8K(;5+P; .;s"Rhy|V\#Y!9wO+lk(?ceݞ 9# :& ,1`]Z 4Δ6{o%ftfoo]橧@$SѳM4PMvz,ʁAJ:vLɗsGj3Bj[ D~:v7Vr9s0/q{$_͝Kb̗LX0./ftsUraRv&$?Xv/ZjqʹPF5C%S!O,_ŝqk f_&I4 J oc.?]XRQRNT61?.. \̾ },\RQ鰙0j;k8e~ή nHwמk(ubr7VU|dzsf4|3?VBe03cIj6 e:<4 9 5l\ψkTf"oap ƽ:ڍǸcZmJ A0j2E'xMf 2ZZU dK* &psCJoޛTD#P+Jy8@) >́鿑3K`P;[4Q.Ӏ)\ dtr.,3pY5evflS|a#iPBA H.22ъAr/^h>j+xfZN8f3`tI1NSz V%m@}Iuժqu"'_dx`JwBxY$@ mêJn K SCј`"Mߦ15,[o,V]&ɦkn='4DsV0I:Iu_0M\n$l<}K}׉fѴbVoy &s 8SXA}&ӘAsYMƘhJ>_h ^[BPOյf4z4N4MY,oSw_QF;n^i~1)qZGp)S'6o7=2olp'x>R2fdƃ 7߂L$(j3l%I#&xa",H1ؤ6P6mvȆݰk2aj1%K}Bt| Kh@K?x $#` QDsO $XI6jwN@Y[Vxq-"͓bҷ2p@]${̿L82jၸ& &b)%b |֕9u DR@aǠvZ" o- g+o:d5zK/×:^/@[{#Ut|KjfpBFt^zT\>ZKi,̠c۳ /;_weW7vҵI Amu13,Lx mp0?bp/c :D|!zp 1b_7֟F%)qҕJ@ QhP7A VbK4axE] pʩ>)ZfΆy3eޱ)o7X&-t0e1./C8 <Ch֑wTP'x2ꙝi}I=۵=]QTW7 JmlZ|3s4MPuǵ q}s}^zӝ_K7ob16] Vx2)7Up[뼱:̝NeوC~wS-?A~Xw#<j_b;9׈,+"!n7s,Tz!y&"BԦS(x)Pf"@Y\6+4b [pډ + +47&?ih)?CkwH%˅m߅+3*R[gQ5 LcAKmtqAv]? ˚z`68nK[_5|V]5/ƵS6`jPʶFff'itqXapSYQ'y0hO3=\[{rm#ZxqaS0h0 " }`G&M(#l"%]]oSE3h6B?"lA xdSY4ː@V %н~trG02)V,k%u&3_G5U'ɔ@6n19H>ȗc ^相^$Lno0cv2-.4,dLa|Kͦ [L#͕<ЀfY}eKb)36.Mh-'rÉ KTqxMOi;i4qHMkO.28G<9Wd2k67 Y7b\\C1*?@= SU2$slX1/?t/DkɿXKdvA1FJ(0܅kt3̬θA bjyO+{4Ͱu,|AaRnsW?٥6^pMMJlK -IX-whqW2u {a>0j5FPPY+@\r;rѪJtLw% Y澬 ʘ+E,uPe&!n11MFQR[ hg},"o-Avf3 [3P@~Ee8E 7!vq d`nj a 1 < dn u=|A[Ƚf G?9>-īύ53ygV"NAP[J)_!ih]je]AHoB5?gmLڀN_Jgɧn]lBP>֟2aH ܺoFzV&H1J¦x>s}lBt/An2SLu'*Pr-m`z'Bn?I||}艝ݗ(ү'MD'3<9ᛰg->.Uu%Ąxw^!\* J+Lဋq wܕ+;`!06OoVvŅgVMˢuFN 2Ycõ QIpd>}w׉d1su9puV shm}%RVfʾES=mVffͽerbA2"Wj?@DS&D蝃}B k0PI2f! ֏~'}]U;`!\bOW hϸu}5_ͮx=B.lgQi\9mhxUCˎ%BKY{JQ@cT? ];GPBK[)7![lXN:<)S.6𥕲-yw‰E3jw[k& |R;)>I;->."[/v*-·5ރЮ tPHi̠5>Q3)sDԠ%(Zǻxi%(ViB[!Z qSd?(ׅjjAA Za >3Un7~ Zf8dz#0t(1%LAϮYkXT^I޺2Nv3=.n=1],wa8rsn;E _^O6LV'i;z q[/\٩||ޓwT5W֕A}W߰}D"C 4‚t˵H(ysBSNZ,$ֈDcɨTb5z:?qA&3~-p}VYV!G}ϡ0?`' ?LЍZ~ϼw.چo []G'F׫C63A˅<\Amz兯RTsˆI˾xO^ݛܿ~dpgk磝[~cY}ugf%զw)ʛd"z!y8U._h5 vF3TRaqXn hit9`xM` RX ya 'L\r9EάjЫǦCIN&@" o:t!62n4f9QŽk돉'}>a;T?ڜٍ2/aǚ A#qh_Pͤpe v;`fEn6tOF6&+Bnnϴq.\, 7@!DXB&V%$! S'Lݞa͗@Dٌq?]@9JWw.Sj')gA$A;#nK'^|raoݤ핵u=O λ *aV_^|ThgG<|GpmDb#LsK罋5ٖoN^z["j| X >}8_[K"`"F 9lDf/teA$&7A B !{ MA?#Z"G CT[_#o\_^᠋Z H &#R%ffE 3!:VzvMÇ|ֿK()VԯGT1K$@0 矚M0rNa*i~]+8u_,W/_<| X <*m=b vuvzyA=ߚmmf`A Si¥~m}@u=g {>O1T+ >9v84x*@Vk=o#^.=E'BXJ   P㸴[[xh/Iuo] n?PNDM+~~ovߡ{қB,jw?hu`+~wAfYy済᫕wM'ipfrF3 YA3 G;om!~s}v=|Xۓ*T \ذ.od|sgy2筤L\o2Z-QPWznx88Zhz\A݇ZO\?*wT]-ApPY4oq+@@꼟/~ ?d_.(?nKja.Lip*;i1"uoɄWi9;w01|€6C± qp5}籲dž.B8o:Y!5enCMU '6\h~sF}h{Oc\&3kg bz/Nus׾20mnvTn^. ;2pU$jݏdg7hۣn#i[`~kۈ *R` `Bh11 TsXAkH8EYCMO~XKV0e 1tѲo\ؗ_dnSᅗrLؗߐW:4Jw;/J1؞K SU޵c:N`Z_n]K_;tW\EB_%(ڰwLm}s4즯y2; ,J}r{ z3 .j3c[<{±nU.Sj 8^^n>K8{@w4>=~`{MT+ta`GơA??- I3!IY9I uAi/=ўˬz8(Ab JbMy27DyQ]i;G wAZIyd`1,F53VKPWM?cР5;7*zꇕulC;k+  +O)Z Da<ZaϟƄze%|^}9VW4Hޤ92B\#vx:y!/P# ܾ݉@ C)&0cMgk%YWV[[m߰&G[#dpf %n |~ Fpgu5-_=;;^QB4ÇKsނȒ-X^L ךGu{| 9;ɒ;v8ݼ} ]Τ^pkk'{}f8J&NB/$:~*R7uaZ&%{T&obj> \R\TއԠ"T 9Uف~* ;<^$[6 zu4%*x 8Gdqͧ]ʚu7{g[^0vMÁw*y ^Y4Ȝ]/%)BxWxgR64-A]0~5Lo٦a`̯]2-&7@<y1kƦë1SL0$I3_M,~/Lly,29i}k덷t.Y{gL Cp[‹x=`O9}GYuv"~gb.8gPk4QLB-)[IW`C^Xw JXl#@Dǻ$hqaD Vw$8ک4tFᅱ8~R$`;C<=ǐ#qƠ$1Bz99N7(&qsgAXXl.٤kya UK_Q>xL@)t!K#&f(CW/ބzdj.o`l:\8PyMyKL Ya g|g?u1*1aȔLbjob d:'h[h!-إϖמ/i\OVu(1.!P-FGC- x^+"`W7,`)4:҉`# v4t=hn-Cs妋[7JZ7Py/I¹c n_zJr:xz&p"xH' ?g:c :/Q8K[9dC,(P fS~J%3c\_d}QCp-A~ C=0; 1l~4R(Wyi2Ig VAgtPhBj9;'Qr)>4zÖ?"bAfR#;UY&I)Ll&7l^m& M]`ƪ\xUfybkbp!'S{ǓD}gc,zpE3r5R-ȣ_xTA^X w[`Jh!X_/Q-ˍ$J5I a@g;K3h>pKK7֥%_Xn⥷x~!{$?|c@m^c9`wAE:` UY֓bwpZC$. qplFġ5 ^3@LcmXpVF XZQp1 j7b} .Ap93Kf<@~:ۉN R 0jx,{PD:b!i~9ͳ\XQnT4h:8.lMtIt͗+QdYjʻ z`do no[ǐ&.7}{ֶN<iGΑ p"_ϸE)4`!L# )6 5>/nȅ[ b}ro!=$렕c<r DfV3au8M w7?k$ u#Ӯ EnXbÚoV02kF< kGknͦÆ /*;@g?OK~>~V]W7Pd.wpp F*'j+ -[vp6f"LH;98S!Z0'fCGenȞhO"20FPcfxр| h`[~v#Ҫ}U|[rmYh*C *\'XnGM*^fwcӼS݃Þ؟X\C?R; hܒFa@\^\ W֦9|Ehiz7'aH 2MKT<4_+ \~ܞ|='g{Wq` h5x۴~rgմG^ř[1IH9f]q0$5D a my|@=ښXX d1B;1ʽ^lFߢeM'e0Mx|&n d VM [St{>cξy%_J 3݆c\aT6]Qi-i nk?}ˢO2 AmXV|/V&157k}QezዯG{^6 `n m(xaۭ~X_OIߥWߤ`t!}W~q eDj@_)tpuȊvAeF^%G *ɤu 9ҝWK] ִ.Y/O~F{CL 3!?l7o-59)Z76`R5ئ]m&32ѕ;8}l.%p^V;5-t{+ēM9*v+cVлX&iwٽhm>;ERe6m(yon4q3i) -GZHkl s& vFmx'V`rs`N,i32p:]2kfY >b֓B0#B* 揪^0j !U 1Ån] + ;'_^D}u̽t]PamV&aI{cXbe6E^Q'=pPjrxv2.|T+3.u6ID(`:R+ѥTkńQ e9_.Zr* Z#Jw{ =#Dd4E`~^zr6eC٘iu %Z 7VfC xD|IW-X扗?Rz ŅqkȀ &O_X(q;_ KʟMA#}E*#B>U5N~H~ LjȆmm +X] 2JH||ШCA?@"ơQba3#oH* "& 3]JBg@Vv[c_[N2$q≯I!\5lo's)ϫsid ʟ>~cAqԢC qoKc.lU;P8)g.œ1{g|to4)3}5[+ ?e5JQ> -\O߲优<1@Xa|[F2$R_/AN]i ˸ۻdM%9r1 V}Hr ғ2|=VI`8 :? vm.1ztF$^V(z0 (; %: AŝP. r3ր@h;eoa1/]suMͦwU+ܔd’ TȘ$8BU;)GV:xjGqYdFoị FCw~~\<$l/YxEeEӆVMYl$R! ^ TNp3 ɟ{df>"뭊QMʄп!T5P(y4,i 4A\ ePk؋(?#i8"PabBFllMC^QYi~6/Vp5yH r3@lǖ8%*r~j-Y'P> V,G AD_M+|1v,pyrA=6H7P"dnΓ@6*Ch&%Z`h%Q4S+ry nXݙ^3hx7—)c'k_͢Њ,<12vXu/^D-:PfbWd8/#%(:8z:~ V ﻯwqp+H}Kf' Aacsnи<*n8 :VV`7v8Hܣ>y$hT_ b*ٞ >g~@ylmRp7 ήRpK'L;g{)'6_<>D لUAϒa`,x-_'x?ˢ[ >{2<*eB1)0C!Qb.p,kt0: aUm Ԅ SzLG%镙E $c DK3u{42l~y @*U?X=c*!Bo61!AR*m>8H0M)wOv OD !n[=ѥ|{n m*VȚ36"`ܢR`3:t3gyfE[BV,"gi;|}?{e؛%XuֺcRh2_r<]K>!KT\ځ6xf }6fلcfa<&Y8. ̄,~DV-T)o0^ނ~7`XtQa:RGVmE"0 гv6wwW1$J$!T8#JuϚ?^/L,q_t(.#O!eG2A~]177u:^,#WEݗ;50 HwRwɧRC& - s2bЖB:P?L *t7L|g܈aaX2`OYdtc6܄ J[obbdݱ>o颰`fq" -EqWS%ZIBZE͕ϸ~OY W:+ T- y~kJda ?xY0;'3rm$==2)*\.?t|?Ӯ&Uq|?Ò7? /7HGE_IIۦgp9PhЧL@b(BHiT9`Sz?ҁ{Y+_H^ec24Y}HQYCIOPw0h?QxCQ"x)A8ӆHβ^_ĕџSӂ}YbҶbLxD:RQj&ۗ pMg|&Ւ&)vd^.eJTtOS{FY i .iu$A/: \\`l[mued.3 <v0l=OacL--&3_^.oVZ4RK#4[+0?nX{xY.ܺrgEpwwY4 ?!H*.qTLV+k$V*#t/OzKDAY*l)vͺ?[7_R@w6\ &!Ìgi_߻Pb:GЮ]=Lqj=AN8@|L’6ygfNﴐ?-4`ZiJ!Wx4 BPeJ4s2*0Ƈ ~m G%i gSεot<\aXce =4ʄ=otb׉rhjpbM&@S0#(KEaVOzS<{`#͑9/^,>[k&6ev9Ut}bc̆`j-h?;iEþ _ĭ.ʡ^m`L:g`o++iAf$B N4=b0& (Ct&Qe2yD)Eu+hE(lg@]9v@b+AlDշE{ɸm %p@` "CG BRŸD~ s6 ?b IB 6B[e,L@~q51MX _ [@5gPL*[\k 1ӡpwZQ<0NEAZ!-aֽ*`~XTTI J=W#BQI@=*%l*6`@Mk.Tfߤky`?30QH^6H _}ZQlu0K}EaU#h"K ҂3˝G*=T[ z6kx^!i2n-=ob׳ڟwN<g=/\;<{ryĥL:Q/\ժUuWa_be-! mbg[|I6(!Ѧ4*~dA; .0y.‹ ]b`Ō.m/Ljj0 4 H $'HBRe89`N  eĞEL!$ 5HX*l.`G-?~[]ϣ>3%Z3dP{/ކsW[\! :FPǂlP|0+xʽr|Y [iq6KH}>[- Ur,kLۛq+׍|!4酷^,@"+vrd8 E)j<";C4X 70\S)=u1لzX0` (V Ya]#;@5P|oVŽw>HX|wdΊ'I$~&!ea'H;Or?Y*wX]{"9Ց3 (7w'14*G0FҵJ֙qGT£i *0d/Uw-%kG\ qicvcɗf ٪3dlsA[L'tvSЂ_R:/`,Kݾ*|);RşJ>L">;OZ$>Z:V.P l$]xbc"&ÛEpyQm/@Afp2$9uFkJFCuh=Vk4#M;Gb=;A&IO~C@MZ9ՠW'`X_3liz2(liJ/^|Q\5Nb?k4ƣ!|c},,aR<{5I€}#O1!~%pҀ!?&쀚/UzoݾX%Xc/qH K120ra, $8VMY~hHpkny}"DiRgRᷯ* l 0Sp)'cOY\[HynW}N.߻(RKÙ<bMUڂi.~Y?}2e|fnNӌoVv"5!hV(A{yoēxU{ILy wNN~$vyϢOχ vz bWue٥遡.ٷG%iRn?hY7!ϮqBS>Yiuı&8qjr `,$3j %?r. |z&.f#q51Fw>L.1v/%[˳v!ܔ\Oy9Rȥ$lQeS^f&dpw׷{; <9f?Kw #`i:4!nLJ>Ghɽ/nd=X!e? !aژeB^%+Bٍ{I"wV \iqm'SlR'x8=99&E X-J s`BlGJr>#A7sbhMx`RBmc%ЬTcR`z>>rX/.Z>vսW:,)?9D  N{t G9#Z 9_Cq*DЂ.9g/a Mˆ Ne9,f1bI&WB#>X&rSH|=DMURnT*'XMN!96(8i'b%|HX5'$33rza*Ul:z,矂.vl9<2赃 KbH-" 5uogtI;"%yz]TgdY{F@3I>v8R6sAaՓRzW$^-X'y?Uϼſ?z+#Й;"UҸ˛`T٨H^A|T{nACS;(Jr[NWyRCdFMfx riju Bvu3p\~Zٮ'kZ/8MCH3=a'.g1īM"i+Y͝s[_ڑݟro^YJn]/M+palnc{zIdR fy=ۥl +Uިmx*Eo-CT5{gPΒ f'nA#k?w%j6xn@`2W^"!~棰Z\Fh=]:mrUjrMj59D_H v &miZ^U-àO5]蜶]Q^6\JX9̕RdsG62:D'# :gy!$ǔe)7@0#(VK-oUifp rl"p)N5"Jx7ik7]i*V͞bt :>?*}CwyH/;8 vEKUZ2WNeS&$ JkRjf|3:rɭNܮ[ 0D2yɢfX?V?/驞PdNy+̘&%+"yF'7iIHT?|L}i o KNM6^Xk/Oӱ6%ʏ{9Q[ѯb,2 +mhDJ !cI`_",HWD|FwQD+wz|k&}Q;eSo Gc//cSJ= @v 2- A"P_ȵ9y[,_^1 ]1T"fB4Q34wQ;b~14!nUPؙ7Xrt!T /j@ XJJ jVN=iq z'Z9V}+6PB螌WU ^^6bࣸ{15O;ljCǎ'olIL"Q#[&s'vy=vipёER:IW< f_!F;aUwEEk묰N~.&凐RT/اڄeP!V'ZqbLB B,kthfVϜy+io6%UJ:] ;r(iLb65Q̰Hhd݇b'ă`ƒ V ԧ4lcVb6$#;T%> |X#<±fi(<ʂèΖfuCqɋ*)o[RL7L +u-j-ANڥ;۰bZ͎6.ʟ۲8_$(j>Jyrb- A?j0q>%.)̜A?_4ES?;EY2axS]жn,P7 ;:n[W% 43` Eu^j`n ڤEvHqלDs!ϺjDr(:ltcq`#-[۞1G]xņ݅b;EVܦNIozKNMH#!xoSR{E~so w![}ci-| }`5&Kז)ZT6f޿^`SL=-$f/DNtՕS:>+ gU{?PA:Ҕ8Q쉛n€_ѽyI1N}F*:$Y{IN %C k,VmSnF<(yBbmWBRO,Xtk=hnJޣo]fwmܦ ^ϓXWgG}T~퐂'OA=c='پQB?VۜV҉s#́Vbٯln& mzIF:(y>{TNdm-g5T(g:*_&mț kďI"o?|eq~>hSs3oM4Z].•L^qR3;QuHW! !•mIi ]39 "jB\pЂ.,T;gS}wiqS,x5; '&U_ iޕ'-aL߭V[InrxBi7bR9W#b7LA'r`ɳypqx :}FH?K3!k!ޯ:cARZ YY&yϛc2RLݗ+Z'gxt3tFpΤs& ԕ֣2L(Zͮ\GKyv}M :W \Au P;>m`y\ݱϺۧ! F*8uW{SJ'JXn3MzEGў_c⬕D!FgFxv8f^z` HjԑyicR-{{?Ja\z! Q1=2o?u5A0Rwcb\ 3K 9On}oQ,~&ZYʉ M4 rJ^e68'Y ]A8V/9>[=RH !;n̷7o=B"YE5ZڧZBN?ܻ?7Hnc%0S*f`,\BJ:&mcҏ 'm@9jIݍ=bdľe{.uџUhUw"OLU;]WUpfZA|b%UuT0a}L9"˗qW"KC331r <*(cL AJKhf4!V;b׺9\bzCp Z-}}kg8Rhmc(ǻ%|1i=ʺ(֐>r,nw'nʻ*tF M+μ|\{b|/Q8i>T:c=O[ܮf;mwW,5|/g CYR+ mi$3mAUgIsHG7O§)ÕlTLt2MI栝tne5OW[LhX# ̈mC-|I=swRׂIxTCc 0A23bLFVVc j||){O6L&&\ojnm|3\w6|3jO}@b@O<iG%-RP|+CV17($%qU"IY $"NxM1Uʂ%gmwbgXv$c'fDA]^[^ARy߄KAy\\Զ@ed*۬6@8EJqp2ED^,n.&pgKa%VIϧq獋s"}X|?2+/)12Ricx+Tك;Aba偃L=;8B#a>KY[OUHx[UӘqΐuo3voe ~/,K^Wكpd]i0GH}0aCsb1R*ꉂ 6FZ =zK(iΉ6"Q&^}$qS oDu{8޿4k*(TA :KDvEo1՞E7)fݏ0c]܄XjJcԜr ",lxsN=AC!V){_5Fad1'O˂0\+jQRڪ:xI}F=Y}so y8哻cDx^Ns˒O,:W=7i I<֨1 0!'Wu߁K䋵K73W.3hT~ϙ7uNk*y#JTÌ?""R#Xt[p)OdK֡fR3l*חMMeL9 f+WloyZi,^9:؃;ꓬen({Sp.9H}p8o@,F44#fT>WxKlߍsA,a?[taq<ERτu!ם-YE8ӡbagUgz r:%0ʤiA[^}R OxmI?ҋ=c &{⬹\3E)<'a LD֤, 3=ohxA.ΓFO`tVh]64 Zq %K ·֏1o;9wJNĺQ1iGnpw1jQ–M~xhv% =d:ٲm)1wxVڈ瓆$ /Lo=?MJ1O#֠ĄF"-@,C+" ۢ@]~w~l|fw_dP)l7mOΫ {T[^" X D_1 Ջкdn<MO(Gy%z[O-wWb27ct£lrJ@Z-H*>ڃ.L89H>G{p;b!϶40=q0RNG ÑgdH$ws {1|%Vm|U!q6w${!<>7{JXjV&!˔Z K=P@ 讉ldxڪ ܔck vWWB{YQ꟫Q1|s$^/h!~B념3Br}V^2+a/}:z ~ECp9ekggd=]pڮcqOǐoQyo;A¦ʡvd}["JWl@zbIEѠRzW,Q|7(o>zoɫwxx?I'kM&K6Ff5[@5?ĖBQXE2J!Xr'g]fo #ªY&ijfy'卅ibX\6R|5S;uWU֭eQ\Pί]~?a5WK]2pS@3ѕ^z E$0祭'^bըHcECR[8*KwTe8^Ꝣ[Ez>ٝ~\~40}|ȼBle^ԶJӸZrFwAiƯF^0O`#3#_ gu ?ӯW5\KHowi|hE,8(BgrT|v[.B;Jrt#7Gc81ԗ6_aL(N-l;nY,-}8DX%.+aX^#3FѩㄗK=4"-Ȗgϸk/؞o#_DADdz_[~8,mmm77=ְ8KIk?~@6eEjTy8V6&9;m 6ln >D^ tD l$e"\ XiS~8L@bG@3 2Adw*#4je^j4 ;:mY RK")ld̍@n*Lƕ_o\ف^AH˺^Sk{֫Wڇ#PZ BwlU;Dٍxb͵y`r,OBz޿IKO؜><[D7JCt ~R:R'u =L 8x0<w1۝6[pQ݃b]݌T1>/-{ގ[6E@5dv2 23WufhZ {GFr>L(ԉ~ėc"#(w}7a x!LDoc۔Gh}b;;ғb3LJMxz7lf>Wq\.ݑuod%tRִɣ ^BYU E@BTmL4zA{7cR SS.o?{%Jޠ9=@ޮi+|rZN"ഠ)Bב`pz;s#n(Esи(J=OycVdb]$6Taljk~ޓk_䃦^2+5 |wJf]^8@ɢp1kA3o;=PlWx"rFrFG#@&pڗ3L5y9_C4ľhX魊CO5.v4[zVTY0(1K ] JCRl;{ܽ>|{HiF)mT#vT5}לDs܏U@A-5"4S>Iv9}~֏ ٓ.77|/yIh8 NB '( wdeֲͦ79 jyLJ%>5: h(j;.,VMME؆ .֟f;Qd3\~)^LW޾9r3_*Ӿ7C$a>zԎKywG%O?&ˍJi3|FkSArp%xpVu ^|~I*in`cȎ|_iw<bO!zνX_Cirhu{#sSN6C3;xMa."݂|.s~12U(To Q6z}svS ]×R <Uόgi4SΌixotꑦ2_XsŤL\'~["؜{w#͍۞>L2DM}^GnGD4^u?db4BnQl#E#PLW ]y3BSJ(f܋T'Hz&p{3[~V)! a1x{r)ߍWػjZGuRF5vj6rxF5ۍ<; 3j% J ~~l ݉'l aXƂq3{pBfIw&nfK%_YHД11 Obv,)[#aGN6-)3hyW'vsUHx(=HEC!1;2_xEyȠskGi#P}1>"'d쮙Y$9|d_wcGrvIb;5?pGD7n&Ƶ05[ah N-Gڟe`4. >U 6 bKa0=<Uv+#B)ERVS Q=SՑM\pdRن>a0DSLFىp+koI`Ho>ŋ4HZ<āU@{.'i@jotUy鞷>FĢ$R*Rddƿ|-:_sAbAz,wCzǵT=0ռ`G| Ch H vK$~k6#B_$om߾~uwBG ֪25byq&ց⟚.ˌo`lBA/~ml! +\ L欠Y>\/ (D|NqUfBSǩ(פkAm؛z\!A*sK=Uo<{r+V Kߑ;W*)v`'bIVp1=cteޡLdO9̆YpI4 Y*g#:fH٪ g(ZO}▧Xc(ϐm"w~A`["HVK·3 镺WAKug.v|7Yq<(Ctgj9|YϐF+C*ngm5!z5XXΙ[gjd1@`y)ZzX7d, F1+қ` u)(+5* aOoJ|YË/T|fG1ė󢄏{x}atZ76­젷 v?<=zyX^ER?@ 'wVt$2R[jo$~dM%fA =F7f<LT EtR'fw>}OǏKSoSmB3+%&M[98h(&IdUJ?o;bC$s?KpF-UJۼeGb(VJ6b0 &4(;^fo#_1G]hzIaT^e$h1P$AC1!\$ z"+&c}qy<}=GI]M7*/N pfZ!1Aq0:E4قN l#\dO,!ۼ ͰB-ihgtU׎h) ȆJGv6]sQr ׵q>_ϛK{_G:_)'͕>(t/Qr;4FYXJ _{z1j(.IPˌ:ez4|}93^#.3wKѻ㎥%qxA#[^ ךy(oXϏ`ƫ|򯛰H|Hn$ȓ6a32)\_1A˳r퇚cqTL2ݧzͅ%9nWU> b $jm"? <f~`5 w# ~C"qqz*1YA7~ v"ӶW>eV6:f(7(8yt@wQs\=͘l%15CG =44+m#VE;z<2NER= #SR f&sHܤNx Z$3r2R$ΩWjpYd!p5V]ƲnA*e_0=@`YՕ!)tW`(:rZ Id%wt*.5+}fOr5+w:L{OA9v'bX9*zϰdw|= y?jDAʖQmNe#|1XP13 CP8;ʳz mGF{Q9ET8E3o+YXx+a@4XH4ڀ r1)D2_~$jI,(fIMМA(f:\ᗉ.16.,!p֕*1K '\-{ZS ZY%v]{΂ϼ#3fq|֎w#UuIfxX=m줧F#W}ll!3$&~v=ငW&7Lz:fT ,+})7{:DQ5?_ڝysBbӠbд5Goy*5X9MdoIkȽCk%va\1bi/yuԒ 6 %晱-)nbIS{㉃bpWػIu8t.. ™Ū՝q"--g6;;n5o?>aV`>2{=c.Ò% )8 e>wxp_U{m7l#n|tk{z4R dZ˅M01bG܎EK'Z-/q%T`J߷ITGx~rd>Ak+яҡ)#$M+_ k{'#qhM GALSzNX=$'K8X?+:/"J< ;m>a5(6hy>;~0qfϓϜR~~eʥ)sS>8} _Wx,D]qAq щ%qZStiN;ƹU^fK%~E}$=DQg6TN`~tDZ⯻+zVLj~yv StILK,跋f̓R/,tGmW"{8?h})` yD"G`4w-bR?;8<dφIE` ? ;4/Bc\pz]KYq;VRY^1+D3 6/Y™ZU]ž"x%F ~<DwsȬP':aę|20idEkA20[$h`GU Mb,)K$ir>JpR Swk&R̘ګR230kvL8-dwZ_Yq@ Ƕؾq<3 ,g,oHa2|T-WK:ƊM@C4IX}2$ZV(ƙY.\%5O{m\p{2 ɷ=b]Ba 2[4.l5&jsy :{Y3_ h)& JDɸﷸUʶЛS+Z](lzPBP6ɲEvP*E ` BңuPDU>p*Qd7Ռڽ dsW\Qf7i7?6EuANr2'ZN]@{w2{ k)\h}tm0EDbKlj,G^Q9ϳ@+hϬj CS@`@7OYZ6mcco/]wloӺ/<0TUWSFA~}M6f9NE9f'PGvH0]La,S{C5Oŋ}˂ IT7s ж8 B/cؘ ԕ̼Xa鰯KZO7/#񲷍pwwd/?BYu5`~a#i<:;U;+lhyR 158P,HTl @3Iy%ϗ,ǃ[9LhK P#B", s'cj qq$~qrk6jbQfESZB\73tQ8~'~_`!Z( j} >iYIV'yB-4} 뫹3}U jmb$,:#҃r43"K#^"xP#K6zF?}+4ߚ+?hfcdjp.l޷YcwYy|+,iLBreӕ߿ 58FJ2;Ǹi: Zv4QKh=iBNd0~i!ʿ0xCf@Re8af2c贪m ~h38_#b}T*YU%3N]2MNVgpC͗+i"=1+"`{U7`(rW M<Ky`(n'e?](Њ茒pV R=/h`鿊2xtzM!&ŧm#5gЦJX9>8(R-[[y hsY˭?5.O}/-ujrj9m)2ӱ1W_WfF4Bs78Oc>1/O f?T#5Sk/GkA'}2Պ[6 i1[> S,swU΅:$)z^KL1Z/\ьֱ)\?q^\&$Op9],ыB_ R dxL4 ֧Ŝ\=mnj=k6?ӭ}qNnnhF u<{ !=ի r}ܱ~FA.e¤^8]f9*=/-LfɁH 2gsx\a.]J}%UՉmn.Z"-"NI$~שfRNyB92# r-S1u@_Bh Ԛjj-`j$~bԠCW@̮Wj),P PoZ,~0*=5V*E#a(L2&lZ@V@ё3$ȯ]vhv- V]N'v6I$yxKwd$J㒷\\>W?dـ;ܖI3㶸dT lщ3%ԒSOM6ݶV'h̠4OI0w4˙=~IBz"4QY9-tFV_O!2'. dl-9.6nz@'pLFQTDYGJL!\ SO@:vN Sp^O"ˉ?Un&LJ.`1iV#d<0;H0r1ڍ1hJ 7F^rK:\)rܩ>CI)l.ҳ̛l[f+\o5,qTlR{] V_'mۣ?Y:sKI4*%c 4S n`,u iBќJ8 /TP|jdM% Odr5'Bd,kJp~'=vv\Ug%=Uh cܸ.4T5jQzh6~9TW]u'8#Rsi7JPiXoRr-wUœ{G?Z ᰊI{;S Q%$dPH%T`.q^k!UXkruZI nNgJV!?_S~<:?> C93!]&2cEZ(n#jA|IBM&*/k勥33Ooo fhUYA0Q'Ȓxv]'Lr$'/mK- g8hRgYBWShcIȺ2ZDDjyQCa%]r稸Y&h1rv]ۍ5#+wnտPk#Jj^g~IϨ) u{9*  Hˉz{ʠP$d? $H4X;Fi9,|[h͞Yʎ(ccr!4hXk~y4&OABR\Wr)+|״ g2~"MBbztcH Š} pEF hPʩ2Gm){J':i V20\7i#| iwo il%Ğ;#fQH va/kτ y!ŭȉqJMޕgSk/V&v&/ Ҧ;O*0> LQ aNWӄi M"lJM_ O3Zˬ/@R$O.9X^e[ F~ y^'N<霒GAk{ +Zq9׮C0qTHXLjt? _.&1~3ӹ+Ii3D8 w)Cn6A]bL؃ Cem\1pdO#@w="3G`Mo:8 "$Jm0"* im~U3e0 Ғ9zEi|YC% raF$&\[,e*e%Hb|Fǩ6x[Klڏ͐bZ59UKeaʮӼ /aG4V |I炮[]%h_.Ă[S$8sJ$vϛp8:iNo z}P665 lYV_"{|'%ϝ 3"[!cKգIj,U &|ĉ.t _a nƶe@'֜X}A90M9uS5om_k:٬u#/is.a۩F_Y'n4@Y~[ZUFMpycv ؘ;G' @RPC}*"QL0ZƮD)Θw]jR*}L<5d}xOOMwciq@;d*"O>4` vO<}or.[g~`e9sM& py<&%ڂJ @+qbSfΎ¥XhH-T(prz/3>k)0BLw0֖d4ӂu2NX$8R"7V(V[@S?5s8z*kڕpWbMY[fgBiO{rl})/e/V!Iw'Mģ8 y'xvg}e?Izbm!T"MF#;q=́={l6a ! .B͜~`=^Y+zv&~L*SpXωyĢF q\l}>Ԫ BO \ _2r^l|& ϡzNz~Eh,f-'y?0;lgMh޷l;pRnkT'Ak Iݴ4g)rC|@du+ x(htwkVc@I\EjyKL8=ܽEvg : w";i%!`~DvqiwGsp]uX;^Lf+yάt45G&)S J\Ի4Xc]*;*1Dk` h W[*/$D-8/`JNLy ]c/(8m2X&_|"r᪗!RydѺ .⠦759;!?1sfwk2ڙP׫jf6҂TV"ՙXFj<"'^}ZuCyt{Q*H_/;䳚%b$tt,3H]kΉ@J Hѳ͖0/OZSթ,$zRPؘ q^:%.-dN捅l=c&VkcoLsT퀚PΟ_;\, \( -YRc}q4SN+8B `ǿzz؈y`]Hɑ(\r;66/DJt5r|/yWS|(U媿i]>5UXqmB+K},&dYrY Hh&pPuhW`;;kv`> .2!^f :m-@4J TFĸPEq875zʉ$q9W-Wh#1ɌBxwC][28C/cEM_2Tk5sf|!T۲%[ZĆŷ@y.5MVd~B g_cQ0=|gQ-f?-*kUMYM0/fx҉fANG| 9L&4ޭgJ0 Q?9h"q.6ã UFyOnXO8G5ȍ1B&(GZׁ%5'#E,WcP&:!,3%׌!l*ZN頚L)kbL@d乿`Y}Q6:EDYvτ\N?(&\rp+dl4J5+ R(b͢b:Uo BA}B7:>ݦNџryo"4+3zz:5Rfsh Xf<2rȊ̝Ta4Z +,cSC| v[%sK+yBf虜 i*yC`3@KѾX\ M=$[x+F[5]O>USu2Bntu݅X:k 25tj؇h艷l=Ώb $ﱢt/((~ʺ_DdmJMyEHTٺR rbyt^)TSs>^š9[<"iFqֽMޣaa7E;]cbω&90brOL꠱\ڼ0/L"Ю_TKaBsBIt6\ Μs~І}65 뀅֛]P'&dncZh~\jk6 q03oW5!Q8Z(j_Ė퐫ʇp "%U~diX泏qBXtV z)\/Ar6ҧ:f2d 3x=_ yTɹo<.(+[Ph8 ah-NB` ORf]OAb` $e(:ԶpIr`2Z \D$qƓٜ1-5o\'J0=jGl_ͯ4iAJks1 xKBҖF[$ V;+)6cCKߍHv5x¿VGWJGб۾UEr4~C"e' (˙< g.DQ~hm /269SٺMWp兦,6汜 q-b:Vj|.P A@ff4%Pi*_3TI]8zZ/cd`쫅rϾa6|U]&ן?߶Z 2˺vwK \tgvw1Ʀ2I:_*< HJ{7mۑQ<(YWW!u\ ˥G.[D]rҞ \BM4,`MkR4!lk%SN]}ݛ:׌[^]g]Ⱥ>YA$߷ܿ<9,rD^YLcQ7C \MK6 ;*pjdm'A?3l5^`w .nqna\(R͞"6,h-hCzo.9aھ/ŗ'D#Gz&)=a+CL4q!Bc\ͧELY&DC8蟀ka3mJCyDdϓTzg},io?oNfAmj=vj> lKykyn4'pRjuq.YMdA yaL* omՁ}e?Ol3z>43sK~KkJdfƑw8B oDv-#[7U97/$'qE'?.#w\V>N݌HV#_e+__YΡl$7$'"ז/\@Oj^c;:B}V9=>T>Zu @. WmXfI\51,ƳiRS,+vmҢ햨g,I)u%8%(djT`wCc5x~{k2vT^r8Uy# _ʶP/Y> 4,p((GDl \ChN I, n\s=pv#JV\ {Is<ﶂ g#x*xsu͵SQa]zL䵼ԛ4OC'n'i6KD_(ไrjvu 2dG5}D%4s?K3y.1nCs>ҍE37WNg҂jIDATxáSǥ9,$>% G*jd5c jԃAρZjmآSKbl?yʗV'O ;Ywc);C$U %[}Om`cԘ[tVe&2P {ej&,2wI2 Z^d Ø M-ٶr~ }4WW \J8R>j +㣥g=3kWlŽ7/- Vfy@<^B&,!lӹ%`ֶ 3#y07#eV* 7E[v*ȀTe41t{6vt1zzX{g'km Xrz5[8̦BC+g^?:}a8(IooQӽWg{ v 藐)%;mZ9_& ݐ"M6[ &ŸD5n/UUEaZ͵z`u@;o/)Kfh/ T@aJ)Ǧ gJ0}>N2LgƢ:-ik3 }M6̹H=3쐆_خњ|Ryij],p.K!H`jH6jO uG$}v17xGkrBp \Qb1? .z%q$Y ӡ;ftrƌDScxSur<JIs?MTwSG=E|WvKDf@#kgKEdBN88ю_4jK%G/gF;^$TwGbNLtL 9q2?ї3&9#_^P"+*uꕹVpel$?,pPϨI)S@@[iw y;_Fs{<uo%)cD_Cԅ5bLdMDayމb9;pV2f|Hn/mv|W=w1Zgؐp 6BSil >+4 ucȨswFm.'521j@wJ6@qa?Poΐ#^?!ߴi7ݼ02}Bmrp&[weo)/r>sa X62]&+uͥ *ooϺ7Xr͉z5t30 ~m7)NanHCP$y~Sx㕿tg/H '{5`}<Gû'n±c.yD*7vp?g/\'- L}6^(:7~)@aIcpӜS_@%}ܝ:aCX2oߎ4(&z.T3)m.s4B’2!:gL0r29j5M4./^7՛"Je0r 7rZ L} GOyw4q G>a^ލ!a 卯Gˁ9ɒ_и N(a^<p| .ܖsVϓ:\0>SaE |H %2.q@vnhCp}?|&oUw֯'8%f )  =)4Qm8sE4<&I=&|Rnj=ݿAldQ(K v<6TzWᯕvаqb#PՎi?@!bEzYq%~WO2(!#֡r"$wᓝ} 9DQnþIjWr.U==2<+LVtnd‡ej1ՙYZ01Yٖ3g`="RhMdDx< TKbSC]BilB=} Wrp&/Hۢnճg/IޘCCe3^+1 qq mL cVKtL/J]s8cW3PQ^ .Wz"Dջ&SPY(ſEg> 6!Tӹ9kB< Rć"w2k N+"AhujOHje !U(CUB?HӜН3ۢ~;~՜gf+)>bK' $N,Hep' =%ŷ»yp XDn#=Y#W{w=`ˑ1Dǝ-~t@0}2wHx Wąmڤ!6a`G<;p<;0j#~LTN02FuD. y7tK'b%C]wse ԅx .! hKu+7rg;/hnTXo* G }Oac(LϵR2:Tۼ>M^. dŖ-ss{9&,״uoGBd|KlqYNz!{=<$m4"#Oy%o#H1!ĴRaK[zL,lB@3m@†PCxYusV-ɞE)=Oy,7䋪[T?z-D$Bn%Ď+z^xf?NxX}\rBm)awsn _#կ+h8u&E! 05^uum(!v EJ%x(ۏt6v{ :#rYX^O!sQV{On(1\$lf^$\LNUԏ]mɄKR|_t]a!PЃφڍ܋`DEhLh6&cMiaMYFW,|LQ%D_)=P ]~_/FH[̌iauY'sZ,܀%*$N~*h Bof6 …U3BvChd\o#yBFvJ..b8tțMSAڎ,ibܜe}wc6/HU02{Wls9ӝd奪u 7'LOY5M|@/o䰩&|p39֗CϑVAFF•YIYufEamgp8?hpQ499#ͭW$p~lp \h5}ix:퉐q_)sƵ=aM@lje0SH g-cJlVQSGd9-?0iV=aVչ#=6OսGH1x~?ѐ0\+5@Ug(WhB{2"(9kHSI"Zs4@2_\ML_~r"6S'3/Lq 0F)\^{ۑ_jG.T]L;Vw&܏^<7]gRK dRCJM63Bu/6He(uAM>tz9oK4|GUO9~Ə^ GZH9 (TSՈgC2C1K;asűzo|hFs_NTc6~7$bD"O\uI7E8^eg~GwgoFV,疦i> p7Xi7&\ d)&7׼ ]LWg\yqg|7\+EG KVz= ?͞ۼ.$J GYB'K98Li_3cREn_1ӢQ7Flw|Qxd<j[Œh#6!ZGO9Vly61|ȓr*Ysqϐo\}1{vPt]wu\2vPuTOoIH8\na?!ߖ7@asmI=>Skr[v}@P99x>ГtO99ӫGf;[$Dվ8JJp㍓5jݗetꏼ` gr@hgdzG抔ݪ$wx<żg'JjZ]E(7սxVAU\Ou*f"5ƽ; il&4?dSYH)l}*l5+IxųCcHٔFqR%Lr"Cs3 ..|ʈu"0Ƈ!nP+Krg7fH*66Jϻd/`?ug_TDF:f j_dwQx6VsoS$=Qe0`UavCY!':hTOo_p ;rݙUF]䙲ﵥbNiP$ܑ PO;{]1f=JqP4ϓz2O=yՑO=[f2GDEXv/n&m?+{9[V* ' wx(5ÓJ;;:RnH٤w珊vH1pr=9HqV(/-Ŷ; @F/hhemkj ʦFwXh94]^ov+w )Vn1ߊsx&wާ 4i'QF)CloCgc(6yu {d8SU''}[BtH#l* ?}:`mz^v8AG# {XjwU#h!38zuմAk^t6`t*_؜d%$]Ho>}vÒi$b^:HeH\ڮ<Φvø&.KvzY xmAG1kFW 4,vĝ'!Dco.^ j0v,)%q;_@b1*~7&Vwj[=kW֣OԤ^g7Vv*L+D JzFp)3H̍*0!"J'YŢclv@7-ug+ʲ27&Z z#b[9^cC9 Z vm lR8v=rgrwmƷ$Lch1V,s*!Bmy|ÝwnſeIgo#ZXY (<ةVgۤLA[Ĥ٘H? mĤV%o=o.>1OҜ."\-ɿa]88It"Je(fvgَ{`ݣW rRIE'"(aiW\ F١+ oLIM6P IJA`Уݤhqފ 6bzu,AZ=GFx-*_c0U17*鰷.2ϤToՑ> Hn֮*A(76>xFj87 najWr߫pp:܎zҦTy7(KXWHVW%ճi8ZROaq+ި~.RfS @zP LVS^jWNTgɪ L[X+u[svɞI1N?oݛanT{>io&YID0F&nl-Iö }\:%s"6`YKbSt*zHI,{7KHk_.5İI{Z_ئ4gӥ+eYEvû0X^]]=<|[<%2&͹V<ɕnR5[ϴ{ cŒ{dq̭cytI};wK HiX@X{^ H҃Yo(d͉bMb (렓6Mqٻ{4a~#u}^0WX5R(eNuneü`Ў)9;?rmCnEǘjz|#JXz^~|vy44qUR6v$OnIע?Y69pU8>1o73awy^Sh;J(`^ ܎XN;Y7بxܖxAlѰ U^i۽sY4_B]~f&Bjo#:e)Mpt 6i\XXK:Gi[3$cHLjg$G(w6RX_ O;޻Y Zd\R_| dzȾZr$/xG䖄۳?G~b#udת^k2/[*ux0 rh'"[QzM3$XeV` D)Yc8XhZ,ZܵȂHt2#}V+tmve^Tr:@/:aӳ3FV4XJa9 ]Qݤb)}tRU:hOdcm탶.Yاbڪ/T; ekVYl-Mw?K/nF\;o^]νyxRM#dX2tr٭:NYQCEv=b0IƧUl50IuRdK1wTo&_Iu; R|5SNʷ%}o8ѢS=;zVW]>ix M-5D%ҵj5P9/>K<ϛl:zK[^@ѯG`qAdH\>#wi[hL{l);//%޾ȸNpv:zԏ%ӃNH)D^E.uIW]e?#8nDMc&lĤҢ ҵ lIlg3ES\_.C8obGq\TXv I@xEC,}z؂\B[mBaE{ۖ*^q#a[V,H+-pt/>"z핗+ HqZmuIBWmLR6OO+|V`GI%n NtlvNBm$[+ącVgtQ*0ϻYi%-œ VօfC[0f%;Y6'W_tQЏNFNCkEŲ#$޳;1wEBoEv FE<vTxrh!Zn*neFo f!j?軍L]}ᙢfZ"3Pўrރ@`1K1˿Kc:pp> %5vmWMA1= j:)Q]85E&hSGi@S4>ΉuŒx:@bt+"ɮtHȿ;*Hn[DWjq7yzzn@mUmZn? S)s-Y|խnIv'*" 9p;XQ RVVf>_.@AW 6EX=.G -S9Hjd KQXZA7*8@}' {F!/@ x,V Wy| rΡ0:W :E/+Pn{-qpIG -0qq9-ܸZ96Ng~y_TJQrZ(Mڇ LՐʌ]qtFvFU9ߎ'ɍ Rx,s)ppSǪJXӫGXdf 1E_Ui14)Zwo d@y`&85t#b0=TRvsJf3\'~i{-XgPjA~R7#_*78" YX,3Qw_ԝhu'ՒYzG v3A7y ;:SRP,<2Ӎd1rpάAU@حVÉ\rPGt'vlo"(as-F%\Ӱtj "q[wbڻs6fHQ8kGGjÎ ɨ: vXM ŹJjSP DҚҚs5|ɖvm7Oޫeo%18S3Od$UݭEVtl,S>98IR ?\Hq]|ס+pĸ<ǩXn`"Zd-ϞWgB$nV MђFQ[si.RVQ=9zYՉ-ql)~k%@,# 91@,Gإ>mX3A֡L/B VY|>{[޾xD82\7\ꛫo~Q H7412y$nN"9^ -NPUgr< +'MjWUi;&UaB[jR( 7ݤbΕΎUfڑU),0Ny7DAd JiG -iZ&(a 7 >ߑ"AidTO[Lݪv֌J9V1~oȍ7_Xl;+(ZL;sIbD^@WBCw9[2S $<$By_Āj]CݠB--%ڋc@w(mŭJ5 ؋)P73(ҚXDLaa)绺b[ڑU';. խSࡥ]mBi`짇rEUc˼7Hzc0QFQ+p06BF'87%+oc{0~!"wzbՖff;K9GaAFIa!ë:K32ㅪALz!nbmȎ>oE#p"jU>t2Ցk; ]eTi?/ןeT+%WϒN%nnǃ˟PDV G"o_hNew2^HB`flti"j̛"Y%bDnһ|#Iv#^lwLqn iLx!VNjA1Z kI()ꃢB9 LuuNGM78+'otWjb\кq_v4εeDhzͺTBaEZ%MOY٨֓nf&\$~EU!7qO5uUU|r=0Z~cARrR qdZn:Ĉsr"b@X6~SpWkˏZmp?2I36PMV V Mas$0^<8@ʤAQz$ ;p9SX> k'i.7Is"^KZ)򑑤jxrt&neHayzx) k7O1a]pD<]@2[+Y3Ա;ꩭxGjʸNGQzݭQ#RWo^7VƿU2٨ " и3#]J \ `,(zHMp"8QƪsEfa~`Izy@,~7OxBRɑ&=I xu9L#GkWMF챈ݑ Q,:YPߝ1uhUNA 7 l];tuYDZ\mS=ڀp Zũ cs!傺Փp 5ڑ~x}5{b}IԩmffC")=%'=!h jNvO+xYJr_!䡚je =T,n{Q]K9&.Jy`G:\"dMӲrKAIqEAjrpA{';?E4{6Z% :/(_1;|Fn"BjGخTMr__W Elu(E $Xd8b6GWLQjc8}~gOIeJ-{?A(CbHS2 AqWsܢ)ϖ[P3,36,ܾ@<Qe+KnkIa,qI Ή,btuC(00o}>}(-x,Z}PLԊx0]-֦o6Ks=|XEkѢ;kiރt+2OryԲ`YƁ_ײ6[Q[Ҍ\:/0RB*:efnw2($0 x'L:pB𺀒 8 b<ѓz<<`  wKC*MJ&"$ lX\:86| ړ *M]ͽzzUyaM-spcFoie)khc%`Վf>۳ZˠOƩPH97x WiDUg& Џ%$w1u_B 1ܽ0 e F㞡*ed );TaSnPv`ib2| QQ# l#D];dkNdAڳdUCKV۟lr}}"_5[+!3JaYo FN>8I7#-o 񉃵D-ϝ¡+!kN\$ ½; (NOvTt jxjM 8niJ5ITm8 ̉ 0ЉH %ƅ"®ojb-uq; NG2c~Ka.Uk& 뎩q:HϤa x=~ґ)w^W倦¬ xW?IC vRV~W( vXrkմkNU3 :jtNPf#$bP'FYʼnP!ts='_8jOӻEEs'f\t&#d փ[Θwd~X13 lIi ȕu}CX[ϟx~,i; T#0ݽ68^Ŏ8DqH,HiJ5Bނ̹jh[/n2+h\w(`0KFTHU8: 1I`= J-4|ݦ7pR]0fhO!wٙQZd!t(J?M&|$m:>dAwp5BprFC.¹^^) Q*{Ό١l5O?'JAb ,?=ӡgasUfn'c 9}"L/vù063MɝWQG;SCဳ J]hM=0%*0 DvPjcw-Ƞ D:WT+Wx  Ž$VNcG 5$^;~^B,cE!^R#WF|X4SF 'fi9pMhb̂[ڇb6 Bs\N $60Vl1d ܕݤJOKHS"1#Py,+eB\.~_ZAQ .@R81 tvmَ֝EdUeh&k.NMAF/zfhbqcoɅ=P-^tXH46o;&xDFSLbz(IiM‰@+5sP =U s)%Qg9cRI6]JC[ؠpХ;yToFO'㊃8GOF1vzKb [Bpp.a²;  R'bDV[((bh< }+ B-{C>a;dT a[G8,o.էw ׮ݕ/Dw"YNSxRR@nK4)wE)ai4 {|ۊc2C"\961XQpR,ʹ(A3E6w vkacec<e>02\nVk$܊hwg83?i|\_ YTjrcO ӊP ӺYU֎a=wV\(!bI"=bb5$i{;GfE~t`%!a6ɀ`Yĥi&ϗHWhs4]GerQ̼+qFd2 G BXlм{l}e2<,I]{cl(0@BhXuay@qM~7qC/Ȝ}[܏8D.d$HəR=p"RR(MeHuuef`fﻼĈF6EƋ9Y-#>!Ãӛ 3t"c(p(o.sIIAzR!#յ'xj|쇆PPQf :=h kC>twsg#>4ks i.U9Ǐ;໾xiIiv:fCeQ H U9Z!юc+؏̩ Mbwj7jϸa*gQ+>hcY?O]溅o t%[ a-ji|?EIW9pD-x ]]=ՊK}DZ MFgPIS@ˌkŢф4[PpjxE./g#EWQoi:j$ 5+F T2%18aK5uFdK5(ێ>wW>w.Џ|+#8;qxATE[ JɺGa^([@,tAF1hdMlb -_^DGeM+F!wU6i#1Q:#L([c=w&Wr-p]egi8kϖ|Ak՛IJ&e!EO}xܾu'c|N?Gxz#fq-cl=ySJ O>*9:;*~\bVsBF:uMpς!Dc|M\<IF%^gV$!߮1[r(!`$бЮI~ĀWՑHP$,ZCt#5B|i6sQbY8P'5Z`9,p'u1q*m^xSz\"Zh$!u ^ [5{HmU1ԻG{<rt˶*(d<))'M),36N uN!|d|+SIfȐF,<Vݶ;IۨX6ЦP͖}Y(V(xj ީ(SsCJ |9';] mQxMR[)!5!hUm]~} EP&:aL`TsL ,r>g>Lp҇X aWr\F&Q1;ǢM}Hq<5л}cG7<c8ǘVgZQW3n~"BWwWxqGr(\YhzeMDD(zSNil{cFuzыN9=s5 YEW)0lK覲 QBuxVr9g3-gѹƜ: f&G!^Eu0VI^ڋZxgk55A/GiMmϏ<$3=306WASjIe61Kc(ժ 9[A I8گ{d9?qBK Y}NSEYًYO4c;{;5INq.bŬD7fH%:6.)BEl %e= $Χ#n P M4چS+gީȔ"[  R7&Q;(Hώ4j\&B}28n:"2+~9@DrH1r}ܧXEށPn{H܉*cp6ygQ7TٺV0V튎fj巰Qd]:҃ҶσZiQ=-*< / ؘo'KDëj"UJ.T"YX"|l(NZ9;KZhKT`'5uj3>gP2NIh(Iq 宰~j$HAjY+4 4fV}8Vt zXM*87\mTr]--ZN+'+|JF2귤=P\^I~Km -ṵ!L[t8S H:d,NXڬw $Q0M=g` w[Os i +`LQEi_vx\g{.'ZXAivJypCPG2!m]IN5(rD{d]+:b&X~wqyYEPM:VG`Z'ga0Y]T4^~(ieL(oEKRޑ,TpiLlK: P=G,G_ģNt&'gAǐ8P%E9N4\]L*-#a6 mTL '%m2Dݝw|msz)kWUS%l H gjoO&q zR}d/8s^6Eŕf~r]O )UҎ}z#L(5?at)F[ЧxF5U[`.gX=2nwາf>TΎ؄2Db҇F;ͯf͟ Tjblz#._Φ/&pw7%BvV|x`ϥ3PIp[5jO]GKUT@jv'Vz>3Sh7qg΃[rnZaY9`([Oy@p>Hf HǹlgkQ7Z'=\_oņ×tfBů%Mx;5VFY[YP$rx6c ܺSNM?>WSL}t=uiBE ڑ6@ ;= * 0AN}7_xh=oaKAU}nY0)KIl?z0Jĵ.X\x|v1pMrmVm0v7z.~T ۾߬%VA4[I}5ag>8yOxdͿ2ރ}!W>ya?u1i5ó=瑥7x]RZ>N4>qZȩ/oځGxN$ft4?CO.k0+UMe8)сsB \S-YGW-F><%|Ka.~~0Y$wOQK#^s۽|no+bd!*|rza8[XXF[xΏI{M"o)FR<_?`|2$E*?8El`$H"օNncvv<3smi;Iʠ9 h.F孄':s&[awS~o{v7o'U~Zxw9&w0+ Q_L7] k4/`zIUb%aȳ 6ʗvPDȨyG#~ `~m, PQ^R.ıd Ա]>,*p3(YaL'bcjU1xEœp㙳Q>jka&`jvVJdpsWvjW:W:g\oӞ//'[_],Ѯ_T`7mn?%< B߾ˮ$aQa(IVv.cnrwl=v.Iid b>y>!ܷ&ͅin5;9ޥ66.ɇ/N\soi=fxhYqiFlRVn{J&C"ȖK}wζϵ (%*_?C.R$Qm 6bcvk@Fe''c(mmh'2m"Om6v1%7xIdX`0_/L&d/Fxi[_-MoĈP^VG^a}=%S)N?$ ׋Ź؁}{O#kL EPz Y<^OvDXtH{ڞmd_/Rt9MI6[[k+/Rp_XzOor+ImiKoVb[۱2‰ebl.}M',̧!nK 3[VTT0l~ZO B |F7*>²t8}6Lr[ 6I~<.o[ᅵnh;85 7]h&4sQl#KXxݻ}c֊|p9{VwF1"J. wHUXF;N+.Z.Mjw䁾\8Mb޻ImŅ۫Io{Vspuxwmr&mfo (z)qʏVm179~[غvn?=OCz.VY C8a$nP C(+^T#9/7g;rnJKBm8`cRjz3Mgy{z2?З;roo{ʸ׮dJkKdjK姓Wz0]^>zлx.xPgRPk"V;_8F{'6?~[)}3˩ژ}0/,Kxsa9=We3]Y\YiXbfbm.%&x->J }Ijtqs1Ū=bPOqKyOh9-Ya2B;`jB D4DZe?=4.Gheeѻ$Qjk\>׉Rথ? Do1wٛKRjs>eb{^zKӻדƷ8v4gk?g| ʫ!6qH#U v8f.ms4˕6Kanp5^oSD}}ua*:R./T,4y"dڻxj2{Sލ2{?XX_ ^r[o%6S]Ū[1i@2NP; #c7\Ƕf ?mM/oF+7,FoVabqxи.{藤;򷺛+\̫ j>ɕJ|8Z'c|fdmq95Kbb6q2[~s9mo,3''=?mlOVSli!zjdzgo -d 6pCr kc Lw'åijm>VWzڔ3f{nLzIi+A]Jt#Xyy5ht6-ΖF_-,o'HOKA1dx(+ݿzb#Rd٧hř=Oj5In2h| .|b=vmj}T~u+6 bťᣯG+KK7z4ʍhm0 4c咡e2W({8&KGKKnh ~Y\.j/ 12ʻXJd{y>̅0Jl|di95s+z&o~o4޾mV/g'; *KoS DZM7? nOeWC xG?<@)7Kv`~uy|1ƽ}Fލ46[_\h'9ȯ.G\Z[Mr/_-zbYx$?{'gRk>s#l ]Y[lf-+=O(͕hi}WgK|n6z[-8F.Mn޺{v֫W~7-l~)58П\|\/ -9H乙XXߎǏW?K,,q`a?KJ0]Ӿxm~j7gR_'1ڑ\]^[Z0zVB1[ISO^[6MWW?,?}<,kš|Gdsk,ʗ!kӬ~'|?r\_{G]IENDB`n"s-,`PNG  IHDRVn2s`sRGB pHYs {)!IDATx^\t\ՙ~ӛfFUKV5B.q8.%C ,,PB؅,i!p 8)cbcml6%KduFhgf$`<߼/=ɢѨ3O4 NkiC8/8 YpZ N z CcAwyNԨ5Wfsk, +*) a0?i[ϭSddDB§G#Fڢ+N# -kp*$RGbϾJuڂSω1AaA S]>&z[Z`9R: "AA1 ~PCWu7_py < rBd_ m3T"oq_G uqJX!_[U?n; HUGl c&F> 8,A!XbXcpQ\󡁼ڰ7 yE5 Ƿuh3E x" XlHx@>8Ehu3se2ֽBoE|׎Ұ?"?dY- ȋfDžOx'6ݽ>xrAтRS%qG;iZYBELE͋bGgfg2^V!ЏB%* e)Pg6L1䏑CY8I`D&'[%ڜl}1tE3}31Yv8 #01]\{lDY@""͌r (UY Z7Uf=-tcE6a(+Asl\8!gG I@5Z#P CA}f(XfP 5A?;[)LDe_T:>@LZUcw|,0kbaT2k8*5e@@@F!U͐ ǩ~V $2NR2ǮEAZci |$ +ϓq=v[¤D_6 &\$`(΅(@bqޓAuvF_oU&H"M KP@rZB茻>rt4" .0^@ `ªOY%!ؔk4:^w/:߬?8Uh#4v>#- ՃGe$<+㒒|GEqi1ޜM(;;i4YA\`") hGT8h ARQp_쀦Mn? _o/2W;"@)sajb7QqNNj\qNtpHE_Pb:0DРdIZ B* .O׏9=ȅ:e-,@Mo!H@rRwRO@Cb;;u5 &$WЩ<M`~ /ZRP_;!.bHOȢf 8N H4ᬩFGA?b{v{ :[dYc!)< e~\ /g~[s6׋b& aԙ*ԙ9!9~3!:6^sK;TZ(׬2hubP=8R6vWit>[1U .N4pĞA1}id!R bpAbVi/;Y&Kaȕ36N)Z@3NT2w?lܐkcqN~ > ],0Nv~9,Up֗UF>;ꍄ$MC Oq3~ 4>JBX+˵@\ygOm]]i馽G;[|BҤJׂnhYkVDnn*{85+*uK]6// XxY"a/3DLIhtF|E}zÞl}Ϡێƕ D?5N&8/ת:qsJN?~-˺/Otl%#pU>/sCq^hfP*8|(z lOJc04sށE'7U ~-C5_.z[a`]Qd: ~Q7kyv4gmy uۂo]Ϯo3q0P@Ţ*aPw (#H4d-I:ͨ)c!(;҆EX?[A 5w-3fqCɌX gAs3ԠKCB0ᕾνU9:d8@zJիv4 6IW+i'IY5 He]^B'^k1gu40] )Q;6!*>whxnKw`zȤqW\]prMlnqSy} ޿A 4w!yZhYd: ~{&7ޠFpOn&MP4- h6\G{.q[T䋛[i|pUAg`^z,Da"_O~pzgX\2RCWҬ9F5P 1i#MQ8Ed׏ 2YP`P`JqY0-i Gz[t' PZ뽷gYC ӏư{M?ӭ?Kn ݞ{ٳO= rao-gtbT@Ƿt]Q,*9W ]OQ LnB?4Mtb^x\'9SU*p8P@pG##,scIѾ@ Pu~qEjL z yngD?Z _8~Jy)y4p( T!bKw^)^sW=["_P9}?U3`P7azcD~`6vlp'v'(8\ӥI 7\tLXx $;@a`` )t!b\B~: Ml־6~VT3 LזЙ/ ň:ND1 raX j<ߤݜQD)Ѡyf3 66FN@sN~QOd@&`^P51iy Mlg?O6t'uDS1&l1H 0"nxEl7cᐪ@WOOqII^\ UUԁ.;v;,u^`o,/g?R/q@T*72grV;͕d;V.FP0rX|:1" iȫ 5r& BK*2EEyy  ]ٳa,8Gr A? e"I@P#%Wp#%Hq #x <_iiX?񆐽d>/0e  8(}.q~i׺W" ,1*B @3my:;jۄbYc;Mϣju\!ef / j/)-bd d'0GC:&ZuR2_@ 0fdIeW江u\LQ0wuC6b$xAw!H8-{qYB1. }F< %l~eU =TE@P4}{U!O"avx9ANq')kD=lrf(+Hr'*UR= 2X(ap aM"rS<#i%YpCI&GWd8q$IF.& ==tXlFg "f2owub,xPBڳϽ@,AO&,vi9"6ECƪL:Gx%mG$q(iȚ;_1pق:$%D 5,XQgFEbutM%_ӳ;"O#(FiMS%$PDrwH D~ Pq<95UkJ~%V@4bgm{ 8*O)Ld>_.J;%a؁ШkNm-wofAS rNþ0%1ܫxC+G#Um<\&_R/ =^'cPL 6?NO_-8Q`,1^U"_٢8P (*.2!KA;f1vl6{\t*o-ɟW̎B ,11u[wp<|QyI3~7yGA5 ^YYShHj KX7W<]Wђԟ$تzÉ%Uٴ@w`wwo\[[6 #.HuaՃ5MMM(L~PWaj3R%'%r%SXQM$aQbk('xX^qd s0" eUT gy9L'5ΧX# udrEѩaS绪ӏ{S p烛yq>_1bHp$|M& lȬۓSqq]~t/_q^uRCat\@U$ [HZ[V]8ISʵg_1I;+D".i҆SkeV ;.!b>І3gxj#\ULo,jj~8 /7K$p7*lRbGӏ'A$Z(EBJ!t(G Uƴ7kgּ~~&3Mg 'G }H#wBBqQZD Ė4e'5 j[om5qk[ZVuM jG0~ .@;Ip0vXF >$< ,[?2ŊMhDjZG|KmJ,5YKjsoA.> @<4Gz9s d.@`P׉HPY e$уp(E@ 8/ ГeZ˲ |D XQMqsYP@6Z߾/#|S =+$C៭;aၭA]h8/Bn\$~@(_DB5癃[.@کb@xru4h=T,&D? _ ~{B!-1: ^:AIo4=*կ,)>B C 16я1N$^ :O8LA@|o>rWKOA9 gIZG_ϕ҉9 PFj?f<وiMo#(e %2^csO~a,HkDa:_eulMU<dlwW} ?Z%ice,/əaXpj= .4 Nq\g9T' !`&.0%IENDB`n- ѪShk"EbsPNG  IHDRZR[T8sRGB pHYs {)IDATx^[wXSgԿMB{[DQ:kmZgѪZWuujE\ KW†$ ?|{{w>*utt _{@!8>/p|o;pGܡch32KK몪ٕ˼-uaI|t odBfP$id[eo13!`ʴ;/sr2w|`4]j0zmz)0b_~;<_3pCc\BCDFXJ<)>k#]}wU%&]\LGRSK_,M/`1p8floe!/)oKN.S1:(??gxҍ԰wڥ)ARnݣéʐ-rMy.HU#%)s *dvCY6^c5"br42zmMs줻32+yQUuI*!9**ޘ'7 k{ckR'Ml̓.PGM!h 83T6)bY6x۪b"--q|>?"`E@P}F~uPaoWZ'VAȆO2w4jGUUTPe DLHJds^';YMux@Onok_ iȰ1R vtTIz*XP,ze%%6JU=g/G^<}*ǹ$tGUTк .k^ I;7 ff&'tcHm< 9*mT,Z/gUkb}\TQ,D K5VnVW2KseHO%ASd_P83h: h }Y-/R8ts}Dp[oO`/ϱh 629%!1+P'GunN-b3 oSRt{TkA0),ec8i$yPFps 8T}ftkk'߯a:wf' ޅl^]C}q^Aأ>!1Fp ?n7cX+ˮ0Wz/uY13蠌m`0,ѝ`'qxGnl<  G%ơ"iĽ;zʅ3ƌUvG:7\PieZZ]GU΃5 %2P4K KU Voefx 7N$%\M0v^_7pE?.0ef-T=2k3s^@!eEx*F=I6W}TC%889-u|6_f_2'U_wrqNFYӃKo)ٟ\Цw%#ѫ7ۈ*m,L_SgӍ'|RipJ_5m!vKm"ZE_/M|pE`A6QJC<`tI8pXOow#]Hgو((AR,HBV:KUy68`~`JqhttVs-_ eq3\9"y-}wܼoVp9W=%od1Ka"Z*/+*K{o+)ctP{j{*2NߦX'ufA{jCk` *ɱѫE=rTbMys_[ KySzThhhˊsj+AK@ջUjĮ9\eWRTҬħhʂMTcuZ r@\\.݂';n žJ@Z-}1ʨ9 DB]{{M1c]$ PX<Lji8~R!]<\^[]"y&F:3xU\ĩ`J[~qgﶧaǸl&5%҈n^s淽KIY8q0ŕ_ *\(9FI?9ySgn>|٣M>"?]SW5mj9wnn.E¹mesJU5Ҵ4jcݿ:s[dȢ2)KJ&Z?o*SZR2eׇm63;si/{sL^&%9qzbN*A%y [,Gk}s]?8Wg)4(T 50s¼Jnѝ,^Д ^?:g,Znj.-4>xha"؇9^) &JP/~2 9-ѡGw>ʊ%ZKT) tPʨ7)U'^ը2rY< ]gG/Y{H,Qʈ2F Hb|bL\tfzvmKKY^DdIVF=g,[7{׆ a"20M(w#9ၜ\![KR#)l,][¤7 y"%)`Ԛl(e˙F^v37v!V(!089)i?ڹǑFzÒNEwCr8G#9m}[&TkFrnJRV96[7a6UtQ^IE=#)5E'kP l fv*X*Yso-a؝-HOaD^sx6WpnCūĸ+洊Z8[GqgOV,YDQ'6rF^kو"f/4T 2:- 76C Z-uǍ9q[dR~qݸz.N.yVũa&|\oMEe_e;wc$] EGmJ5u<\Dg~)wS"X8.>Z6RZun'Bᕐ>+6>.KvyCaUXQ|\MmnԾˆ3( ?k`Ҁ(aؕkgfQUʒ" ,BBEXϓ&V80M0Մٷ8 ei.)@]hJ)v'U v̩&V~(T(AomKHbx" ѝvWf~5 )%u< R$t*EXC水Jp؈R522V7mbphѐ2%I+Cz*ɐ pw.{zΦm&f BOtj >k wSZTVU(=TVHS2bUM]=ڔ؆}CC I+SٸԇԡsF XDu}̨Uĺ&e gw Є(z4@Tq vT[}am =$/N̓$i%1[ ܹʂBvp 1  2o$4՜GIEJC130N@y3y')`!Extp[~GLXik(57.<>ϲjUȰP7|Sk{8Z$ kk [}5 ٠>mC5btB2ԻڮMԜ5n3^PT &{7no=e -aé#a3P|H]z?y(VW0In\Ny1-V''ZUX3uJѢgIA cw )m,ia= Dҽܳ8v^B^'G󿔞;yWPA8O[ݸv}*5|`ȪW/^kihlDU緡ȁ~ka* -mVN3!R=Ut=/3m`ƭöxGhWX;$o[Tb= 1rfOE-dcu1s^yںQO3 L-MQcCggi"a+Wsx_B^=t-1DqS .dflCFGdii?NC5$R* ˋ3 cDKo7o{'{G/{x?}lĄS[7`2§+;qDŸv /Vi =2b܈WosSK˛ͮϏ̾vibn<ָQt Q8wP ?0,O6C D̢:i)h D1w\:B,AIv3m2N̳Z|N gT+ȭ4C'uhz+:>$8|ީwD0 nNDaP?oKKY * E 3\g!031 < p5vLv\ИfCFJD#Dd=xϛ..n*-5Yݨ65uvt4#Dd+h,;w,1obI6ƺ2&)յS@Ӌ)wuu#dZn 3Ld 642y~d$RM} f~1Gz7 Snho#1"*Ew<7jlGXΔ_F#ـ:ժ,`χluԕ+E" rZ[?hSnc Ok}… { #WM)`߹122`{tC6*UEmzAU 9yEQQyl %mNꤲ\FScCIDKs3){<$$ٓJс̛YjaA:{5&0` <6Ii5l7o%gJOcԬ{]*Ȯ%:^Җg0,ijBF4GmrbVssTZƹX}`hhI*_=}:uT]''0:N"7vx]d:v 0&N3N5̖J6?Kgȃ\̮b : t+ :;EޏO`Mvv~0cFLDC$՝2(ʕE75 lJa+$pLYaptGIE fқsCTp};ѻj,6mmrz27C YIs]L@q4ȬYHp0f^s,*zrɝ/| Ui\P ~X7 2Rw6x٭cR01[~>_U\ύ+k׭o%ᒻ; | @P(eC,\.Tep(2F9yt_0ҒGIr2Ϡ¶~ڸ5I #$]TO̵#{,m[\a)YQHfbmMPt,@>KuuxTTFP7 $?ڨ=p Xlg%_uSP k5@HOYGbd,7RZgVޝf+h!YOQ5hJ~>t9 'OWV"͇lۉޱ/q|"&i=Rn"ĨA"x*D/D00z_Gb;adu_م,%aj5iېmIv`?Yd2./j{_ DA$A$-fi""֖0(jb趴K^ITE7Imx)Z.yf=: |(N|<%7{ZW+W8~PJZj얟+@+^.n03T)wXm15p(+KP%k*l͝3'CzZPvfY폨B`5 R10̱o[?.WWAjp9#lm8ɝpv$Dl;ߗqxH/dQD}`R"VY񍍍{ S3V*B8tkV8gpȪ!M{+}8PaXzʮ _~4b#{X:>`7..Y~8f ]zkTO dG7,=O+73~5;3`"hPa8Qn4?/_?qڸh$_g[kUt(HSc1jlQMGYB4^hL UTP  "@=,;k֬̿AիW.X.]; N;''ФGGG###GZ: s8Ç]M]]\Qܹ45SLHH5BQQQI z8;@ {FlT#'W>փ`[=,ƬYQ.\066f]>p  <>x𖟟 $'O>/#{Vؾ},@{䈿SS+32nwu5g0@beef^ܬojj*ud%M6-Z"bs=Y؋?VWWs\REEEe`ڞ7nx D  ooύ}TnHxӦupEECpK`$};4NGHEgyׯ/a.L8L:qb̙#L ڈ͛Ai,/aBBc:?eeE>u*C]kիI7ύ9OrΝ;۳tiiXikk#o8IAyWd4n~7{ C__GkՕÓllҋm_mKe"ᴴ=ެvvꖖ.Da0cⳞcyq4-p;nw{c*%K߆ .^ZSSow%t* zHu$>`dHsNF |P M;ӯyK0YfZvv5SY[ ɮ bx{o)edd9 LCÆ1/y3W^$<iiq رķivvwޕL WS{@`ve}F~R# Y$xULI"DBrɷpCIyØ@!yu:Tv̟ؒ+Zp.vC3\02KzC}W6Vzm] )Ϭʎ"S'hS#nz䰋E\FӧOߺuJSCUђfae gTv0IvWr4]Feb6U[l젦|"B:1f2'YYYIXV6T_2 ;mY/+vUS_dAb(,Q9tPIbq*#!qg#L͸FK\HKFV{|B֏ˁc *hbkSS!ӹJKVکq:TUzF19.{^H^9Ϙ1C̱4dFFUY/=4jʡk gHdZ(B&Lf0Ԍs.@""4'؈ƾCY.K3g|{;88O?f_83pX7O<ٵ/>ٰ/[K shوd mM-(ovmܸQ0xi|T&9t -m~Æ{r:tJh[ɥYqPe!62Mm۶Q )b!Ǐ; K+qXU`!e4iҾ}6:x2;vS_MQ.-!Ʈ.^0 l4u0?_`HmZپ9d߁CFVv6.n-]xIDDDB2˯p lo;E%`? x,FxoA8TgwY| 4 |;)>mnrMu3XL)Sؘ;Q^Q//_C|1ꬾq_#"ŷFJm@&iYi X~VLֽh\ ɿGZf͙G=k9ϚC}ϧn 8< ބ }aV=?1˱eR;v+~FjB|wq؉/v/S^7a$: 8{ߊxraƂ\hL ԜK뇄1#-|0]~\cWJAl*[< TWݿ7B`Fؾ4x| 6>#=7-~~^9$oڰ&?-UE^~ԩۿ6L{gE:a1~"`3gvfcg7 yeˉlD% 揓JJD6hD>'.`unTxpS- V'&PJٓ65(flpoxt0 lQ8Y49Vd.0mO֊}6+wt807T/VQU{~̳}Of:=MM ACpM#gq Z/~?W!L NLh.Ԓcƾ >l oHX{E tZ eillo@ZzDF BтO!Og~X"@~CDԕ4lﵜ<ÈI+11Jq*JK윜ÏR1 lk5wtF%::< VV*))gg|`*)*AA|ƴ8FZ"wd^?@wVYYLgP!aA6:?O(khܱ=22%;[I-N;AĴ"+ `kƦg̞"Mmy94 od$FĽl /3[zmfĄk)I)㷄~EcVRMw\=%B鏮2w&l2h(z0踸8hMP` }[fX4G;׷d-aTZlݽ%rIENDB`n.5QcjI+PNG  IHDRnsRGB pHYs {).^IDATx^}xTU$I $$.5HXXu[>H/!Ofz~CI>I&{Cuݔۖv?KCRl6Rt:V;$b͂lL&c2C=lpGJTSS34MLL$p] 3*?`#"mHΝTMvAֈl 0Baebq\RRTTTxx8[_gggmmŊ F#MZ U*VK'i \{2J}$P; +Ο7l ^'N)-sT0h,lvFV$mttM̀!yҥsEE:MMUU>xk/GDD{rrMttEh` ]23'LpkEr̙3eeeBy-oo-`V[_uuo%ԛbUQ[V}628!3PFo9kΜ$2b[ Q 6""t䙌2ͻ(l<ٳksOWV)oa?ƔSSB`›yi4{c]]a f$x11.nnAD"ӷfIaaѣGҒ &L 3f;ܘW۷C`bK$i.2$ImFьd z&`ql1Z-~ǎ#s7ߌPz[l<ń tMՎAk=mQf~|֭` Gq?XHDl}Wdx8nDm10m0Q4aE~>-Ylt5E[|vĮg QQr@0<;3FWWl>4*oq0ݽr(.MG}++s?/ip}c*}q223'uTV2j;իx)3~nn)C>߿h2McU; GB䓥yyy96 {\u+:xB233Ǎ7g$:(//',x5֎?qbJsau,X0­>޴ 8T|9.1~ɓՆҐ@:u ŇⰵfUpcEfݺ@8 x O=@N._|$a7oYp8!^dm4# pA] W B#ۨߎ!axjˣ))&KY޴愄VW~k1 ZVfGzrhɑ#R+ubl8\'OڻZ4vjΜخ.@BrpfQeeQ F]xZ^;ZE <-np-VėRkkrbNu-3du:,e322"oǗ_Br.P?NDӧ Uq_^ .]'9Av[Ue~ ZyØʿ #Kx2Y5<MzFƎ8YhKb}2txg%=#8źX^.ELF~״Z6!jVN;8gޚݲn灣ɲ:b}.C^P,f3? z~ oql<0W@ܿa>;!Zbw5oƕp.nݺXjh [hX u1\$ Vish,d1}?0ܛv` 2XgTORPL@lCyb `Matb4y /(-aӓN7~NTZe]Cn9r&{x[A#ya A!?@ߐz4..g—[R~ A, &}+\b;FLpz7aL𷓐ESEO?D£RɡeKbIyW_7E*H{@ #DX,I$|x/ og-7UPmN,Ki4^O K!V<2)9%4MZ3yş%f |.W("TGUEd4[[ `_1آxF^ y$Y,~}oH`YmU%pivBcs>tRHFuz~sPx p~n}yu0^~=so[:[fix险+/dlbLEjƒ5+-ګVU0 R G )#|564&DFLsxXb(Np)]rzLY%d|¨~} o{ I&p &'ڽmz?Jy&?5uRZԃWO4q7&f .7 wŒ@v]p;1ڒFfu8VLN@@J\L( TʜxQ%M uF}=6nF##ҷ4N .Mh)ɉ/9Kw^X赅OGydkÕ4|0hT|5υY hC .Rw/]$M0J*keq_t qhoTZpLYw q4M+jf9tZ;{{H?h㐥;.4>3њNT4:O{^8vyÈ e6R;>Af!ł ?/m Bb޵16.vf2:96fW0H548p okh yygpC%klsB q@9jkZf~ye۞ A!1?UfGQi.UzAߕFb %X8_ 82&|*&'{o D>p`'L^CY$qWk֐h? m%K`2%P_Kl-C]i4oHf=s̜I|!/bmn5EUխL$$f{e`^zʁ2 44Y%F #yd' F:2,FXvcblը03˨Lq/,Pi"l ޕ+W57iN'{ƾ򌐇) OA|]¯7{YҤ IP~j J HkD# HG`aQKm_} =LW L0h %71&>ԛbB\Nؚ5k_&0:1o"(?w:NM\ ;?H!ˆ%2l2Sפw,z3偗㸝Nӱhs=9^Ѯ5o놇FM03^cj`~Ɋs XZW[+gEdL>z$9 H_oV$f2*X n>}_K۫ [̌>LI\/ᚧ@.LHWG޲pkSnK=7>LLIѩLwoʆI,:ȅ4<= xETd.HvКqm=v$7̻ӹ"1~9]?Wkѽlԇ~Ȁ nذ"F;i骹ٿ>ө KqUfs1c#5vfʌkI5Ï?*.P-3r(OG?z}椛v ~oz}fGNKv_)Vh))xP~+(]43mR/r^#'JX0I[^K : ¢ } ~7ΐkj Bc>K eA؉]Z͖y6d̨cq1hß,0.F=NhQ^ּ|w8"f_^xyǗהiɘG<{ܚ2K>km`̇Fʀ[L wS/J ^]Ug7'AL]cd-Yxn 'ZTNWZQ" %}ތ֟=~x]c٧$299O[E ״ؽ 'W7LS^@eQYAXE_8rF?&BG ]Db40+bY0>#I̜&Yނ-\:E!@o|kkz-3;)'vM_wyzσ{g,4*4MZ{:5\][7Mq=f7K儇S \8tEEkD"(O悿]xY闬õ!=MF~{}ضW9K{GˇLJ [zM'# Yj*"d4'CaupcGOo?J3VWDq //{LP.E&2^984>͗c՝o5O:Wԣ??s@o2ufF(xuKf_:oZ\[2ڤ+NjTC.+<Mt ݻu/vQ 3OY'_x_p! $" D_CϐヸX>t~B -Mr)erjNv;U9b4#x\=V{:MC' m_8#Sܔ(gcE%䄸 f+U~04cA.+!k<'=՚Y5p:+s]qh{/D1 Sf Wp'yw͙cf2 ĨfwwLAt|RHD_qΰs<},RۜJ4az^_itZT~gG3x&}{ brI'7!O7?PӓΞ#Mkn%%_ZVМsLA7N)zPAy")רlM~f)Q.?~߉bT*Ct-&Hqb]1)+ _Eb^-EamrM@2m|i .^ltcC)^*KJVIy̸pbǏÙZq+ cχQw8Pi~1<+PYF״Ό4>t[}mťӥ%]\[,ՎS7?/^wv./,(;B9]]ň:g69]KnA@U7պL|lZUK׀Shlea/GF%Mzo_dSCξ0l[>3]G &snѨ&v7X3<,.,^R4C_Xj" D5 "Z\SjaX`;«ZͲl;sjjfUW+N](Mڐ JApN@^@KKggސX$O|B%֪E3bYz;P93%-*!㫳JySRr'7h,^qM]RW62?;˳kٻ`!t{t]jU$(qvQYy >UK:|ize݆$1%*t r|S@>1B`F ˪Us$A=qFݥ561&%\͝XXoh2جfMtĄX|{~l⤬{J|wKen 4R Ucfs{&k4jǒ#^)$q1ao<# u$5nɓRyu &궕dA&M@kXpd8:ݔij2.RV#cht:u-[#L筛r8Mm&7Z-^Kfre\T{pzdJ"pPX۾b^F`FAٝ0Wb/8]$If测D  ^ŀ,~Ryy-M~#A@8:ajnDxF5H?(b8mbUU̴™}7d/**G,HHK493Lrmi~*S,\(6UTeEy\nCԧ\ >BVIFMS!u)&Nl-\v!Hd){!)p}ۦLʥ`dCB,ho$0b,Zhg:$:U;:i׾s!eAkx]'mJA")o9hKt5w5T+.bCܵZxOLګC%f rh\.GKT jP.nGx:y~Fbb7ߐg#˖-Y2d ?#X 1by#azQض5ͧe-x\%~YcO*X|'~"U[,֋q%l#c`@m}g ̟tf\Ӆs Q2߾Ka~!$ǭpSi8@;/] R$'47Ǔa>BɯaC ɮ&l @b~;Z]YzO-B+ګ5;Ndtj3̜6˪SܪjPj Usr UUijQI|#l}诫= X=}>*2*rU &Ԅ:_}?l|L{IVw? 5 yL ʓ;S#+98Z[g~5%)|7IS5)le靑zrj݌HԥRGGC6q7N"qϲMؐPb/)]zk;j`q`jWx|mxwf[ii7$ B&QP\L|*N)aI$PDl{v6Q?π"DvK\2*II]eYez&-W")~?+ܹ=4H+랻ߠlnTrUmuZbl7$"@ikuY Fȍa]6 K8tә]伤`qvj c"Ti06 [.;LnA렎`GnH`29ј ɔq:x߇ 2aEl]~Vv9?߀F2j^ԙû31v0!l:| я7|u|ֵQ9&o뿜Sq*> DS}$8qÇ}~(ˌY:@oMYp ĈkϺUkGN nI ZkH& %gMt:ZL&T'9(79-Yl`NQ׌/(+/Glq- TdHұ05ҁ(nD TBv1ݞŋ?ñF5oG)U݋JJp02nO8}~˨Cu}%T\|?w8 F+?|{4F˱ ao~>x`^^=faxӽf$&b 7?Xٵ #L0PrL!) .$ὠ7?bciJg22yּydƆ֭#/)3UO)- lp 'xn֜979bط TNLPMlj1#M hBTzGb"%rz!º8k @WU}8֞ *BC DeZf&NUA1!`7ummj[˧S.n$\f@ص\;S0^ ,hԨSƾEQSpSguRpmSݻwoVt%`5`GDD>|7}Wkzvt^N im*F{69htlVƵ4- رcwAēBj4q.\Nx=p tX4hZΩ ֮]o }:=27c 9iKW-֠ T`˷n}rF>*ġ-->UD3lذ?ًO1 ( Ldu7>'vz3.O91-fUU9Ԭhd)0бeYU")/VB_,[ʽ3jZ-A3Ec*zGCmBULl̄WJk٧ZME#v4*_^099sӌ1`kݺ(PbA"K:fn&ܕs"JcY7'bD~!QѡWGOAXM~GLSg]>ٝJ@WUJPe̦ȕVRh_JB |n[v)X]bUuM*V *vck5hƣjDmnܾ3qt4BW5lAByo}Ν;V^e02ocdTƹ_o;95TхS|evVքk8;"@2 [ZjEd0ynvPKJ PW0p'k]`?aઅUYJ@X42k& xͥڭ?Sm NM:O4AդW#0TDVh{uN\x|,_I Z͇2Q~;Ԗp$IQht!/%Jz5z0*JΧ{!ؘ]/ Etr"l\ : *U卫ݸ%;Pi^Q(}Z`'ۜYպ= P fE)K78qt=B^o VK]5e~_wmއ$Ďl Ygg7|s+׫&;t|%ioApꆹ×BB]g/,ֹ7Ѷ@Q xr)_r%j<V;;;"?_ڶmȀ'$ ⧓> ,rq>c`1t.5E! 9g:Oؔ{ŕ5bGoa 1i)@q%p$ǯ -&&/[X֫ ymOq& ^^xޘ OOݫ׊oƫ`{#Nzhe`Ai P0>'  6Z>S2`aywK ?[V(1lv(+ }i ˻?ffgz$Λ7*/Io}`1:HVX * ËMKYPW@PIeWז;=G6& $(#+oP}D6LU>H7,5t7|XTA ɽ{4zygwHNDo^Yͻ NsJ81&]l [mrkW)-gs36v rrF4|Y.Rb XIؗՐܷhqET@ފ"!iP5:2O."TlyYZn铞_p۪8E*/r0024Kcb=YX<^^^ժ.NxZ/6+'~}R%3H,[Dvi޼ڡCR2޳AmKmúU ɸi@X{ Ӽw k,W0×!^ݻ7;wQF`}{Ƚ7u[<6ٷbbⒻWzj ?KCe2TRPX:PNPU@ U(Wң0a+-7J!*QF3r$%'GGEa&I U0!M93}R|I@XoqI H 1vd;` ~m=p9&QZ 2 | P|հ}m=.V2d113,8n.>P֙cYbTTԜ9s׸rxNjv΁JMvm\\6Q['K=)BQ[z^FK=ʿr尤VׇeWX'zAZ*<<|ҤIQ휃'Fbc1&6!E;k! DAFl|2m4Ə /lFF "WM.>S6މ?c:vHQGh kAܯ_?"޺pYzXØ\0\"I !_N4{zJYkU6 %+Ē k6m]ŧ#'b/APO|071Pҿlъ~ԿjX ÀMU /3jsssᯤ$ q(Ζe@adQ<6;)T'쪷z*H3y1ۏ$AV_]UZpr|rTĈ#L ʕ/(O0ߓkuu (q0XWvإ'55I΅,u(9~՞l?0c{#hLnζla4fi#Jk~iI&DD ҷ !uSW*5i2[Jv;ږv?B]W; /h bx0[1+*Za"_P10#P!ֵx N/[0N3lN- 2PȼTXpZ~})ה )*|wʢyLy*|gLIb@;Okc?~ʔ)44q^9z( oQ^d )kcrUA0dC_hş~Y@1X pCl ׫W$9YZju' _8. © -oTݻ#5ݦ`@PPXNg+•Z_jQ^3 )vܿ.]0Jh÷ڈ? Qej)xRR oe˖-Xp{, i=^|ć; ?k#a3`CgR%&OJxd\yKK WTG t#  ap+h~25Z'Of :(4⒝;wJ}vMWA.3WUj!H ëbxf,の]C|$"Vʕ3,w[Kpz@HC_ (dO+0'L6=>>(Yû&l{7l5L~t-Իz`93/h6kah<|E."o c䍁֭&`Dc Cvdkw.0Tb`ȫC&@M_Um*$۟PxazmyƀT-\N \Nk5Y; @1jܸ1]bji9Os>Pc4m°s۶4ssc1G PG # ŞQȐFf.?S+FZ . ;p8<, LV y^XP[ԫ u#liaK^^ގىZ؟ic395xY`Y6:[ЗK4ZTa#N1MM\Q[c( }eԧ<ۯgNHBVt$8`\{8+|z` 9 MrY (1O2 T=_ ,"!gitL*-k j傯6N I]| d8\̲ų…hv7&K5+F^qoRLkQ]{NbR恔(T^Y0WT6'9)S{`Kq!0"EbK B"(rNbf ):skJ'xbɸr#H]ɳf9;gUm_V7׶!8ᦂΆ GʐJ((032`,#| t/8x*a9?D@*\NlT^үj学LfTWV .mXGYB{ZMcin)BmI V)+ʹ)N\*3mɞ,&%*TdL?+'v$( ֖IjkZyM@nY+\H%`e`SGyThI,"T/sEYzHхK@t`iNit`!,Tt`iNit`!,Tt`iNi uqSIENDB`n$aلAEQ)MBQPNG  IHDRʹsRGB pHYs {)aIDATx^ pUUPaP+!DZYChZ"Dli@;VKheig՚g([Qf bJECn{9޷ГSR/{gyQ_G뺾g HsP@)%4S G@q8qBTW[۳G9L>}.}޵hXifTšCLTV&}I,ѭFdGbj2Rѣ%s$#38}b˓ED0{SӎDظQK 4:a7NS7ud9s)@gP\sM4r +b0bȐ€r|Ͳe,>d⫠nT={֬\"ԤJӧgё,lìY)0OEsfe.YTm+VĀ,I[ИMAWʛP)*g a:0{(Ȍ6UNb"6/I@/)LG47B^ 50A z5zvRZZ{6$N3;:iGx_wϔ@>%F4Ɨػw/1ӇCB,C=ȍt%$FO HMbiX@ p~0-(0auhRB]DA8LZj{#[9i?~ذa{Q1oVX00uQ|`jxCuhp|2$~-E.Oslr_reZbG}lD` 椩Xsc`g9$ c9~h"08 &jχeR K10TDW>q`1bĉ|O_[p${>J7\ Y|Ig12!./O}wP̈́eyG}_}QVgA\)B}fшds7l`c0d0 D !fCzEM hs_xH3p@Iz(77-%Z|I@)!%f 8="@/@t_xHƼEP4$ =065Jnq\R=4?qaAegK/0ŀ:=M BC#5@ %; ib$ P%Ѱ|S@B{+x"WU1߳uw7nׯ3?`m3B\}Ǐ5jĿwqAww^c&r[GQ˦ȁ~,^/t'IcUYR "fPR$鳻ފk]$5O*, fXTPmKQ]|H~M~X7~L߽s;!??y#(EEEM6U$̈ʲm[?zV3K+VSB>*ډ{TA:$V7 MV@w0(3k!:Ǒ:sq_+}zҥ;t` :) X^.ާ?nQ[4!M p|WX1s=z͙솊-g+o@f>p ^.]8l=ZN };_"'Oܹs_߲뛷бS.͚5kҤΪa䭷޺sa \w!M! =ٳNrWAVVNhٶMYY.\'Usq8Vj':ZEWCaf>o^Ac;o*~[X{վTQQvMަ߷luB`kCџu T=[f~cY:Hʄɺc/pcS=XQQG|mwߗf?QM>Zh ]t% SN]t V>#Ǧm۶;]JR/]Ă^-F50g]Gl-Pɭ$۳gzyРowR&rvٺu+ԇtRNNE#mr'4N xd ^mrZ1@*Ƀ뮻,l8oЪ/ ~Μ9cy%hw% իGs_U鎤N6W鸫 M,.YYY~۷ǿ;;-򦛔U0곂ֱSN~^>\m.YE AiСsmݺuƍ  o( 88k׮e}۶mF ݽ(FܺԯS%8s7wVy>9/i|ׯ ǜ+MJ ynݺ8qb̘1˗/4hP@#GGbH$!bȖ>7hP@RN9#//~G竌*ݵV:F Ґ0< /ZSЈs\@FY(0hM0^5 {Ww]d8rk-{ 6ȝ`Y9W;H/rKx zF.[ȍ֌mƌq|E+ Vp=bM*_Ay}ѥ\,,Bˇ Q6W4kC[8 C;4۔u0jVXf̀SʽrNDSe5}j&Mw:ujyy9yOeAiʭ` @ET2|2s|Zt>,J9 ?!\4]xW*S"XU{v7>ߍL qR2Dt9IN."m8{J|zSGyŋoISHkk֬Yte+D͏:?ҪdK4@cG>{d&`s%OV7k^V!$؟!i[j`4B hW|8Cl57P|A},/݆"+9ph774i$??JIXja6oCLr5odwPBm*:Έ63 ;3b}Pi+ʁr<5" ѮeqIy_RQ/ѦՒ$cuRT(PtyFPI)ֺKLJ__e$(Dg*4yuc}-fwEm@Ld{` cQ|</$Pk*9'6Mm/4h(UpD[,e/#;88⳦{bm r($ǯ MqsI|j%->}+nl}owbԣ.\WV* vb'8JآWd!0Z`1g% 4kTx餒^&UH-52ӵjj`xd]€??eO| =.Z*K@Hq֬ = {o t AR)DU$!^؁)3dY/ۺUO|Ŕ̖ṒEn4 m*t4;As%- l^?$c޾Z1+[4Py4jv} tELr*⊢EZ[@Z^i=i^H3}(UIENDB`nl ko EB-AЎPNG  IHDRI*sRGB pHYs = IDATx^]x\ŵ޻uɖ*7Ȗmlˎ c%$@LB˗ /{BqHq!bS bnpWl˒U}޽.銐|o?{uw9s9g2pXoZ`d}z9رcw~-Jj-hFg͜ K.U*AG̙3=9X>SG! +l}>CX7uA׸\_bh# [GGCagϩUMtbYM/ bU[xo//_0{c0^}{ qފ65JnŵB!χ ݆>rN]5e7N[F#^O<{aM|J񡣣8].-fӨ5s?:u̿GFF{#۰mn҅/S(qA6>tӅaLp$ s\80$xַW\sϿȳ/lm~K ny}nu;}~_Ѩ3^xRԽ7X,ፈo ;M?}`z>Hy>kʴzMޮv Ty.|3k:u}M !Tb󙦰8\=f6p]h_PP#O6Mpl#Փ^xi#C7бD8I)Tk#"S?f2>w8O[~@{@s;<\ȉ*ZC!X&Wl]-_ҕnj#8*H'kݺuO?t^^h4WXڵG*BH$OvewQBE.Ir]w\k攔NjǏ///8qbaaᆻv6*0UWW'|>߂Ʌ]?u(v}Qx^Y8 ё!~E/`Uyw/SLځY:w :oQ6=~o_YZ9L?gTs84ɓ'<]$\P3+LČTȢa6kMH]R{As1*^hôg,,[W9%X4J4щg;vhEX5jLѓFXs7$\Xw& M}նIg-8'vp1|xE(pc=DֶMWpɤ?5EC^FHy|_ɖgK}n뮻Fo)<"cA'.u<V$ y/SW^znl^\htJ` eD,2XVRG uojzܢSXH y^|N?ʃ>8B ydd,<d%Z1~JqiʉF."C9&VO*8^FjېӾuߕn}( 64^eņ|,l^ʔ-wy̜,_">Qo%qZ~mΝ,mFSWUWnG_=&<>, _1w112^?tQIhY܅`1#ng E 4wCAQNF2dY{_K51E0DhY뵳gg$NLep\+ƿ"[q=1dQu>< =KX#r{EF]V]VvΝ;ͺw~ѡXMѱhأo;>~O__dx\&:Hxf,جA$8O\qMz $ 쮭Lɰ~f) WH]O78f'w(iu,P?‰="2$ P?䓜[EkbVi 3rI."-u*\cQNtvwoc9,h*cRojH3C̈́ 2pPFP ី-w#AK|F,0yF|~U+yܸqpwT/d`E21E^o ^&l}}}"S!n@-1# CzMr 1Ay"ǯ )P3| u69etHC.Z2]l ӗ8c]I@>|džyilaq,Zg! lĐL=@\W3vPRD MC)\F#t-]-!=¥ӧݑiV7=mo, [cc#!OT!JzG4{$> _{!O{vUwGs Oޟ@VA i?}GZ{M&lmR$%*Dg嚠Ub**E~I1e]z>%aQ[S}qV1&:n0mއ~#̄홓-m)VN.á30px#&,ٱ|ib-H #μp(@L-#>W0ʼn*DdheӧO#p'JFKn+zS~`&J\dJ+D& Hgd;KƖ@ nӋFpc>:m=UJ9>fT֬9.K.Dtlߠb~́am߾]Էu{!I^.!ȔB^[S-[^z my.l+3xqAl{!80Bw~TH#8V/Sj2(03?DcNW 񐪄x#!_Xl16e7DlXV e#S_n%pI2~lamu7QiĄܳ@+)̓+U'97 z 0zؿ١̝};ʍA :7hsD1YERTt =z0Ib]*<ap>S m +zÿJչ= B Bʐ ,ϟ?Μ9C@MbUDy>/ oFZ$V}r8Nl0>':&d#(WOsј Mƹy$n560@Hq1 JY :yI^G$ 5+*Z!;6,ɰ%?ZzRx J< m43r |tFph2ċN^HPJ.%;6V+ΦH###H? ?|HsX!HX"`=~N²PKq^<#MٱMCҮO1nNW,:qEn@0дz#a0~8@kjj^{5o3̆͞H&:ٱ RSd:yUK8)(6%hZXD:l'ge@uwpG ͚Bu)9;+W8G̅3 8w:ӐEE]3 8'Y65nT>]sT"U/RogK HjHdRI^QPo"$NJi,IHVտQlj d'FRN \̥-hkydo{ȥ~:IŬ @G-^}>r7ÖDݫ포 f+24qH<-/+# 6,S0B]$ G!`/ρI t[Z'yQd0fC&> 㟬ULhԊG1z:uA)LbzHt )D3LTA@(N&AXc r)eқ*f8fW+|A",v)g2W6E MG"PTLL#0 ː7 `*+u ԥ+p/x/"ۙ.N2 `El Gq! 8 :O؂_1&s" 63ꐣa㱃}=!v6o 7^J9w]Vf oC[(U3jLE v`'Cj 4j!LJPPBmAp:ɡ2P985+7|^Q_JG  WW :aAơt$B6wਅ {FN NX0M*i dZc5MQ(U,1lb*= 30UMxⱟbH݀y鍿tPB`{gw @J|xr;@HϫYl9bh4`2 i%C.Ո upWMm ` qC.Y[`bפ{e:8{Lg2"l@uͽeU;+@а,:HZ9dlckձqj~NwyH 5 [>2MT(%onM ]oȺ ݖ):i٦W7l!;|AI M~a*h9eUk{G ۶&ڔ;}/dƄj]W[ 䰀 -v.{qdC]f%m74l]OHd hokn'zTT BW l+S\T7a o:m˂X]^*\PIf!f5k:Km0咛oQ%̓R.רjBTdGIowX6=w0 9um'G Me4;vȈ9`l%كU@7F͖p0n÷ߴu @f1vISf܎^t,¦R^9  U63ͭ'L 8pStT ͮ Nm9=H cv3omKy|ۘW7T ?7Qi R>{͝5  N׹FiX}.ۓ"ń#1*Q1+,|Hk8>$aw0tM{4g%*xTbN#@*Z6oj8& ]2Tgd@>؆a+dPh cz8`B;=m9r&YI$!ƴs7@vXbG EtfnUdVd5=’94qy}NHDA&Po9d]B!ug\5!2ќo9V-9`W`:.ޒ3*IENDB`nW$\mUbJ7PNG  IHDRXYsRGB pHYs {)#IDATx^] xSUھiҤMthR6 TVA ணˆ﨣Ì8:.(;2 P֖oiڴIڦ{{&i?Ossp4 up 4n"q̃H(Hpn9QRR¢JKKKSS夲g BoooUP*555݅2СC,$RTTqpc)Z4GqvvJ^^^ut}鋊SRR6oL"E1 (M_\9Y:xESTEQTE}AQqqq @(44zvdSN;wn֭thk)2J/UQT EURT<(hLHHȯkDGGǑ#Gv@Q4#FLjKJ%LZ),ʦqqS 5lkжmvn$E-l ǔn|5tgGW`Btq.vC ,KĊ)}̙^ U̶]ޞs/GN6ĠY(#>gx(=%{W766?~ZɌgeeتYB\ &+}, 嗬'#*&(uϚ(g.lY6]|OŮQ>-15*EY[[EVv=S[2NUi"{^L5SEy9]000P<  dì ǣ&{S;l5R!ʕ?I匌Ϛ5G65k}5Yw^7g}a55ʳէJ:/-鸼^T xJ}remz|# u!7|P^Y>cҘ!,+>1^cHٳG)kTZHѨ9/);}\yXiєu ՚S7Š1xZų?vww|...W}; R>'JD"Qi8^d{`M9_ڇHC4Rr?3+*Lj\|.JQ%Tyˍ>8x쐛[f}S9Kޕu>>?[uƃĮ]_pi_5Py8о#KrpY5tkR[[ {SYrP-pp}u%i3,"r-wU1fM6({w}sxbݔ/`lmc0pN"6X 2̀S4I">u)/YxyiIa^ZThYbKz3/ v_ڪ`RG&[Pc}dy`Bֳd[ B}.?* *j^{]wCSu?8|#KJ<$NA b:[\'_pZ@O5l/4+im L׭y1at?؋O?X oa^$+Wq' 6ܳJm 铺]Ͱ:!  }ta0V]^i[j<< (yWv2vI9lBw+tYR5_< P4NdPcCرcQSfڬ}}} 4i)l'w+̎@^:f1[A`W VڑSy{Dw;k8WKkMS+]gzވ}ݕ R4(w}ffَRalH@4-}nss/$wk2,UB:A}1 $(o|~|35A]͐𬛇wRRfyI8/@OĈۗ'4cPmg5%\:9FGvc0\x$B3gke H@VW7d2և?yZ.Rx7IjhT";$ZstRqB3>HB#BVOnz ͫ-|aLɳGb-[YDWVVnrG E\CV^U1rҤdPc@nWAC [0(Q2r}X_mlVtŽeKg&?_<#*Kڅ?46/QЄm9cF=J5T{_9wtڵP6|B}M=8rp+?"Fe+>14$/2|- -r_-Ӗb529:׋(|`/Pu{-zn؎{<FȊ?~]۷uo;v!W^?3c냹ݴ^XK~765R}iq͔sw-E&4|?2Ge#N-^"ª2[є8!RwT#-\)s׶6QAxBFAjH8 +EW3ou{^8GuRB#X)HeMs/"N?.=kLIH59s([d]v 1I^; #&T90NMln9!ya\ے+Y-@lev6S,׿ͻrKYt"qǡvRNke?; )m~S (0N+7V\kgW 5щ~o]>JNtLl޽i" ݯm_+3pz9 i_UUuĉXR?v!W9H Y!(:XF!7# ?W97H`A2v5Z2 U?ceō:mƶy$CӦ!*y8#`qC( O( g .uA*M a3jhU'7"wVQv##XKiVzOx*0Mph+zTuG~д?CFLl&cYlktzJ(Dp2zc,oЃeFn6F#滫_<0M$ARu&=f&Ӡ7 |IӘ{K)y|#wk\A y:LaQ3iNA^nNRI>fM:DkG̕'ʺ6*]K ReLgTӺFUy98T)d\UTAa_Lۉ#Iq;M*CT0:z+ m/Zڻ~I->qȗIGC=$.@^cFa}>НB+ҁ 49:D0C ATC_Rk+Aڔi8u'+np#_n]bH7Ⱥz$.ELJM@oM ʂTf)j Ry Lm+mH8ɫXn̸ߏFH" VQ谘PkEEOF7[ò1DŕRkc |"w~zIANZ-Ԕ4 8SC<`<]88.UTRtN^,c$CTGEz3W} cf@}ȟjXʎy&& _2A5t<CgQ^[zlE5uMյlzG*g.kNeqr@e ;Ls.3z@~o@ND컓ޑp,扏d #Doہ))i'|eQQI>tu4WVWS/w;ى8G(sި*[T٧M\{k*HϗחExp[_[%X.ǦA.Z)>HƎxXc2](t ^~-߽jo߾3fK?+gM*ҩ s:r3:I*P;9^h9>rt躻Ie''8CSUt5T HaXr$d5+ #wbyŵ_ܚ `J,Hkt^Byaݣ"o*))򞌇;)cyq*̈IT €[z c(.3X3F/GJړtRT~A AzGV7(Xii#ZњA5l®و{K,]LF˺Ѻ< LtvO1\O|6eP0G:-jM}[wAuXu"(3ҰW2i_ۚS> mـQXݯ˽,b Gc۪%\2WCuتPfUQh̷:(57¥QՍKpu ̑.]}ӋRyŏ.|*s{f{X@@HM999Iq&7[/Np*qҵ3T F>z,1>3w(2XCHNJH )E;"̫IoYhtr)gN Scx(Mp_`%E6c $Xl! [mgx%Kh\l@KuH*[s{ʔȮ-d!5Ah`ŋ !3]8]9`~{B dW$}=iKotea>Bu>>/-(SS۰pZ{{;r j/ W''q BԇΜ< vةT7wd2A/Xzk=yx@r֎ ^;'\ nKn^jezI]tp)UoaNn~/|V}LLK{{{LL eK"dˢ&ԍYzkx4M%lF"ٴin?pa ygt0Ne3_9S`7?q•ǖhjƢm?ќ^7hfITLYR7) ۚ?P,}+|SIZ ,Qsu [ Ofm,bnޑvF'49Bw_uQڄX{ %фsvq%2˂ t*¹Zy-QAX(v3mw9Nގ!p}'7'pGl(/~q爘q -~#"e5EpJvHK2 6_DlmQf6TU +\ P,nwר :]x}]Ba6aN$^lw^ڷiA^AL=]GXfwZ۝3z"}AхX fta;1̄1ƌJ6&=iO-nGpWXArGCyܹQ1>P`i*3=Ӣsw"q |HnD| 8[B`Ϛdﲷoѐj*, 0q7lPj{&֩:}dnY X *h렅S{ (jΡyf|M@!>Hm0~oa֊k凡!fS7u3;}7!'+N_mmm0_%PWqArv39 fÆ7̛78kX̯?X yyy2E-?^"?`O*fVhwBxVb㉣1ĩ#HOk0wcq`7ȱӕtn9{m@oTOˋonb7|qOFᑿZ$ K7k_NVF("[(f 0K9ɎT `Tiډ)02$%?Ĕh#@@ ؒ>h?  `HT `T 0P$C 0ڏA(!GG @##AFd @uF@@#E2@ @P" P]Q}~@ (@B .@>h?  `HT `T 0P$C 0ڏA(!GG @##AFd @uF@@#E2@Ȁ'?إO?g{r-\,Jxg\vI.oLZГ}6\Z-J ސwMhG7|f.3T_Mx~EU`[i5s mC ~gzj+~>/Y.=-￑24~eꩧdLKy饗f;"43ZV￿퓇zhf z-;?:хGgV86ORZlJQq%{iBS_QFZ=g^#>f%p2^Z:э\aXq쳏<{쓃>x=hkd~M^xn_̔Ip!:>;q{=3M7di<@>쳫zyO<ą,p} dGqD[;/\p+j袋|{WЬ{Ҏ?x]aJSOb 'ˈw}׫eR-,O(ZjoTJ̔fU8&qQ8S%צ \qV|ߛ:묳4$N6z[~]_m:)ZW_}uEV¼C1nҵü;vaKcnEmkƱC캤ݪnw4 GՓ'WRJ*LAcՁT[WYY<48] k}'Wuh@*M.hqnѹ<`j[ F :϶#:+_4j,*] lkwfA{=5m_~'/dQtyS9Zۜ3y'5*|'Ҷ T\1c^j۝>mٖf@ѦH{=}'=[K.тN߾zgScћkq)vE38C?myr*}G[y>c)'t>YҭВBKQu]^{i+uQ17ԪN?m״%J^j9 VmׇJYYJzwLP>`}+im\?ڊi=};Bf'6t/m{|KkYӊ7=r fhȯ 6a'C}lzӍճ61sB۰Qw|j]Y|[L>Gix+d\@P |I# LPKvUhђֆQG}dG`f:eS]V#:Ǵ 6֕ikL )u]SL*g 4nwqP'>Ƃ&سp-P6kͭ/OAh';j;GY85}/}ڼ1bBֹ?U\=D~1CS/y i9BWĶ1.ZG\ Ứ]o]'-?)_x.M{kMB1m{ Ӂ &S*X\JUL6Y57}=:-ѻOxN4{BOkفj+ӟ 8sd50oU5ٹbC,,`viVMo0МV[nmJk6':6aW@qA5gM5kbAgVxC_)B/ŸXbChy7yVG(_We)eoԭے:(m3ن,/W_}+$  m=\xU5Wv/*)ƣg ʦMF>W!e}H?B]C^iLA}dE=tay}> 7`Y}Q B^eoTU6tgxpӕ_SZmL+nolSUW]e1í|3Y"PJlUPjy衇Ue\6pnsC#Gf+nF{XX{@ipȻ7|EU+즮Ω+ǼN^{omF:ϳ6tF֯ƒkYޫzD}]捙ɫ;t[{&V qcطs케SVmYO_Ş9ז?hu{{,/S%uvOֶOsҺ:@~WiOC譳5pֿfQS5lM_C_u^VJV*~U!m9_5зQfacS‘iJ~Vn`t>h?7ޮ SΏ6po1> [ޮ$nE[aƆ?<>Tċc$#кw捁 ͜vGC3麯՟c##pZ,إ] Jl?Sz@!2-̵%@c5GV*@X)7Cc5GV*@X)7Cc5GV*@X)7Cc5GV*@X)7Cc5GV*@X)7Cc5GV*@X)7Cc5GV*0ϛ @`K qb`#hEȊ@`7a0 @B@@#D"@c@ $@1@@ 0BL$B `0@B@@#D"@c@ $@1@@ 0BL$B `0@B@@#D"@c@ $@1@@ 0BL$B `0@B@@#D"@c@ $@1@@ 0BL$B `0@B@@#D"@c@ $@1@@ 0BL$B `0@B@@#D"@c@ $@1@@ 0BL$B `0@B@@#D"@c@ $@1@@ 0BL$B `0@B=#F"@@#6QyXX҃lvۢ"[@j Ui5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5 صֈiA2 ;XSFh[,ie1Aˊ)=hfi-*@{P5V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZi22 55V#iF  @MF~ @Z&# PSQi5  `Ȁ `wZv{5GZ  -Fv4@ X &E!;Y{! ˥(@& cu(A%@X,";L:  `,Kr@&?CP{?YSIENDB`2DdS,dcr  C @A(Op911-SafetyRed125w"`bl~ 5Wi,H&n@~ 5Wi,PNG  IHDR}…PLTEBB(($$QQʜussݵzzJJ|ͬ̓ aaJJ]]22ybbպ;;ЫȢ||ƒٽұYYƘ<<Ėֵʐ,,’Şllˤ̦ƙhh͢ϱղǟDD™bbƑ޹nSSغѵ~z{ ܿAANN̗\\77SS྾w ٱȎ11bKGDH cmPPJCmp0712HsEIDATHKŖWW]DE aE#hԄ)ִM;w jO='ݻ;3;wƺ=/f)/!lsnŕ:LEKCfD_s"NU$Y >ԽwrGTpLApo~Ǯ:1һ/opWw4vzv WD)W]BT^;_Dn p#ByǞe:,w0M8ZM{^۰&oY'4cX}/eG?%avdI\ɘ[Jps{g10:6[,quIb,νQ]BﮔG?9E(sv\ϙj r50f8h@ET%}{%qW? 7_` upf,s(^?3Ză8"NcL-@`,1.i6k*'ϋ sFh)VtMC(,oic*_ TD.GoC*e_i=xro&b07qITJlu gxȎYS +Fpɇ1Wh ,XR&+pԭ;KS"VҲIf]?U~J@aWYΔO|\t+fw+sAtgGݯ, z?3h:H#;A<ɂVu Cn{I8[)f±cOc& a7%J4'.m:wUsr4dF+[aN$BE&5L+ -z:sX1ŴmZx]ْ;.KDᢥO:8I5 TSeCNZVXtuƬPCTne__~ -$R&;gȺ(*ՃK͏Sy|\ꉕ+4pVy)Cp&&Ki80Ը" &Q+^H4%¢%qg ȦA|Ro_c2,҆̒t&ybTdcZn<1zrtSӾe=U<.yjm6}0PS};m\M__Lb4;Jxؤ!Z}E8@{1 ko v0j|δ̼JY*ys}ĥ^IENDB`^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH DA`D Default Paragraph FontRi@R  Table Normal4 l4a (k (No List z@z r. Table Grid7:V05$7$8$9DH$|o| Bullet Text! & FPP5$7$8$9DH$)B*KHOJQJ^J_HmH phsH tH 6U@6 ' Hyperlink >*B*phbo"b GuDefault 7$8$H$-B*CJOJQJ^J_HaJmH phsH tH 4@24 HHeader  !4 B4 HFooter  !NORN x2 BodyTextdxxCJOJQJ^JaJ*W@a* @*Strong5\.X@q. @*Emphasis6].)@. b' Page Number\O!\  L Bullet Large & FdhB*CJaJph>6> {> List Bullet 2  & FHH dF Balloon TextCJOJQJ^JaJFVF zFollowedHyperlink >*B*phPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] nf 111114g ? k4"4"Rgr*Q4hDFJRWualcRddgiWklannn8:<@BEGHJKLNOQRTVWYZ\]^`acd C$ );^GpOXwcglnn9;=>?ACDFIMPSUX[_b@"=v4c " ~SnfXXXXXXXX%,.4!P b$VۑR 0éxR4b$KM$n\.f#ys b$9&v%&_sjD&b$s-,`"0b$ѪShk"Ebs5 8b$7 1;dg`?mb$5QcjI+.Eb$ {G] wb$$aلAEQ)MBQ22b$ko EB-AЎt Hb$xik- Y b$\mUbJ7_${h@8 (    C FA._LogoHeader700wAug20103"`?  s A "ôhttp://opioids911.org/preview/content-images/creativecomlogo.pngcreative commonsyK _blankyK vhttp://creativecommons.org/licenses/by-nc/3.0/yX;H,]ą'c#" `?x  C 4AAgreement400w#" `?P  # A#" `?P  # A#" `?P  # A#" `?P  # A#" `?P   # A#" `?P   # A #" `?P   # A #" `? P   # A #" `? B S  ?$V\\/^^_a ccnfL0D%Tl%{ TVT %<T %T!s%TX A&T *D%TT  !D%T  !$ T %T'*;f=f>f@fAfCfDfFfGf`fjflfof:f;f`fjfof:f;f`fjfof8?wڡ뙖u7o4HhgZ6%}=r$l|Jl"-WtLAeuE2W5@"ƴG ;(^Mf.ZdP,!C4,6G7HhgV<W<1p*N^/Rfx$JMX n]a ul(hp[%t^{v"LvHhg ^`OJQJo(,(^`(56B*CJOJQJaJo(phhHl hh^h`o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.,(^`(56B*CJOJQJaJo(phhHl h^`o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH. h^h`o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH. h^`o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.,(^`(56B*CJOJQJaJo(phhHl hh^h`o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.   ^ `o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.,  ^ `56B*CJOJQJaJo(phhHl  H^ `o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH. "(^`(B* CJOJQJo(phhHn ^`OJQJ^Jo(hHo pp^p`OJQJo(hH @ @ ^@ `OJQJo(hH ^`OJQJ^Jo(hHo ^`OJQJo(hH ^`OJQJo(hH ^`OJQJ^Jo(hHo PP^P`OJQJo(hH  ^ `o(hH. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.%tV<$JMX!C4n]a-|67}=r86G7@"0vAe/Rul02WG ;(W<*NMf.{v(hp%t~ȱ/RB        2b'        1                 RB        h}h6        ~MhEaMhEa %) */):Mnuz+{ #%')/3b9c9J@[IRT1^ *-r.0)55JBP5^a dir~~ -2;(C"LXOZna8x|]<#36:D%HPPNUT]_z_hXi"lo-oKr&J%v%-[..^58K>B@CEH5TZn\@gg4@NRegor"R$_3V7>?>CKLLZ?aru |zzN22;KOw|~ {  VC rL O 9Z `    G U W `\ l 1r s R! 6 7 WC "G L W X T[ ] Q` jc  " 7 /= L M P Uh o $u w O 0 2 q2 C? A I O #r s ]y } $2 ::;P=A!F_z~   Pcz%&&>BRf;g{}$K !%'{ORuZErWkTR ^ %.^/=6\R]]}bu]C&,h1e7<>?w}  !X^budwdfj mu6+OBOE~EG0QW XZ[_cop;| 9JBV^qc)oQ!4&ISPc.eAiow&&3>>5?@N QjqbbQ/:<:QUY.ZO`d1mGnzO   8"#6CCM=a7cxemlzc !!"+,0\2;6Z9!GGmrsCQW/6:SW\^_v&(467HI/UrV,d,j5q.CENVYdeh>} #$o%%*@IKOPRVl;oo ; t   $ +& . x2 `; ; )> E yL ^ k kp Ju !T!!u ! !!7!2!j5!5!9!S>!K!rZ!qh!% "G "] "2";"R"qX"Z"b"f"mv" #b#c#B ### #w6#9#;#J#N#b$^ $$n8$J=$&>$-?$G$=b$rk$k$m$u$D %w%K%%%'%87%18%@%4D%AL%L%9S%`%t%P &&&& &!&$&4&7&+?&R&V&^&#j&','''''2'W7'OS'w\'b'j'1(( (B(J({[(}b(b(f(x(p ))!)R*)5)C)R)])^)c)h)q)p~)'*a* *f*1*6*@*@*L*{P*ZX*)]*e*8l*+ +H++w/+=0+]1+.7+:+:+;+<+<+7E+G+if+k+?,#,Z),?,D,TP,H^,_,kc,o,w,--'-G1-2-8-I-U-]-_-c-5. .H...9.`.b.f.h.(o.v./ /(/D/X/k/0m0N020t"0R*04090v<0H0H0T0l0n{0}011T11Q1[1f1l11$1'1*1S61\;1P1`1'o1o1z1}1~18222223232628292:2H2K2\R2wT2X2c25f2y233 3v3&3t(3i03%53M3W3e3j3u3 {3s 4v4^4 4?4q4(4&14?>4P4e4j4o4?q4x4q5a555J55f55t55"5|%5]85?5A5HC5E57H5Y5 `5j5k5e|56{6A 6p6o66(6b)6.696:6+;6X6p6t677747n671K7K7M7U7Y7C[7b7i7p7Jr7[8I8l8r"8!98@84C8F8I8:l8}m8m899?"9#9%9(9)9=E9X9Z9Z9[9\9a9g9n9-p9R9 ::: :): 9:::T: Z:)d:[g:j:kk:v:z:}:;;;!;&;@;P;T;L[;5];In;n;o;y;~; <<9<M<\<(f<n<s<z<{<<<===S!='=*(=.=/=;=I=^= k=rl=x=/z=}>>>>*>q>7>H>N>X>_>j>Bv>{>~>???I%?j&?'?)?C-? 6?G:?I?K?]?,_?c?f?u?u?lv?z?@+@ @"@#@=1@F7@L@AX@ \@Sb@m@w@|@@}@A A A~A+AA3"Ak,AG>AECA*EA^EAHAXIAcAeA4gAhA(iABBPBb&B9B:BBBCBhMB_B~BCCCC]C4,C-C/C:C>C5?CRACbICOC/YCGYC1]C_CeClC"wCxC |C}C!DS D D{%D#/D7D@DED JDQDQDa^DaDcDWfDgDDEEE2!E"Ex)E-E4EEEE_LEUEiEoEOvEyE:~EEF&FF'F@/Fx>F FFFF4WF=[FdF4fF pFpwFxF{FG G G,G$G8GJGQG(SGYUGYGaGrGuHHH%H;HsAHEHFH IIIb"I5%I%I;3I?ICIaIeIigIvIzIJ J.JAJJJs)J,JK1JHJJJMJPJ]JE`JaJ{gJnJuJuJKKK%K'KR)K-K8K{KKQKRKXK`KkKqKvK LCLAL}L Lt#L3+La5LQJLULXLaLeLoLb|L LMCM!MjMo M "MBM_CMJMvNMPMSMUMYMbMdM gMgMJlMN N NNN+Np-N2/N7NFNGNWNZNvOAODOGOPO%^OpO5PPP6Ph@P@PIPXP\^PdPtPxPNQ4Q!Q;0Q9QA:Q=QAQMQWQfQZxQ R/ RGRkR:$R{'R-R 7R0;RCRGR ORnQRZR^RhRkR S<S5S0S0Sm:SAS^KSQSbSgSqjSxS{SIS TTTN'T/T5T>TFTPT_TV`TfTxhTzkTlT~T7Tz U'UUD!UT.U5U7UEUgWUXU dUmU}~U VVoV(V0V8Vi,^/^2^A^B^J^S^qY^Y^~Z^d^f^r^^F_(__$_H'_O(_I>_J_PV_W\_P`_}_>`l`H``[`k%`E1`@`K]`\b`J|` aaaa(?aAaPakhaZjasa~abqbbib?bEbKbtbbeb c c;ccc$!cN6c:cBcQcTczcddd*#d3d:dMdXdbdodwdeel eeee"eH0et6e`eae8fe/ue] fy ffff%f:f=fFfsJfJfef grg1g(g+g Eg_Igcg=hgzgu|gVhhh)hX:hqEhEh'ShYh1fhiiii i iii!i-ik&?k@kCkDkNkPkpkwklU l ll'l/)lDlVl!Xl\l?blelvolvlxlP|l}l+~lmm m)"m,m0m9mGxCxjFx/Ix,Kx;OxPxVx^]x^hx,lxox6y yy yNy1yy (yE)yA.y0y0yb1y1y 5y:y_`arefAx{~*7< P#QZZ\fLl9pzX0j94;;;lOPWsllx&)0AKN:PQuW adxc^ #_+ 6GOyP^k0o qY~z",/I9?jBW]`Hm,o6r}|O HZt[sf0#%1FMFQQR {=..;/5 9>EXNVW\badxf*O+G1 >?J_VW`gum3pt7w9xz8z d 49y=AEHI&N@`o !.<sA.FIREWQY[afw')15qOS|[[ipqw\}~(9/DQc[7\Zu|#} -@ ETTYZiAtty[~H+/V3/;$DENQm (0156E=kEEXSp\xro%79_<CEDFG0HvHQS\^q(w_~?18K>ADPQTbdnz*m*9f=8E FNRZT\9b@gw{r  &'H!KMZZ[`oo@s)k:5;R{WX 'e.445DMqN ]]cllmu|E}*:G-1:3I5OU\cmjyi%5*6+X8ES5^S_lw+| I(3.5=7 :M1QXRfklQnw~G <fy~!w=-N234@FlZ^fr [#$$)2: ;p=W\~_dOhjko)ss"t# wbw$,9/9AlDFXHN\Ux`5dq{yN%4>ILR^-eRsYw9 )<;J VWB\I^qOg:wBY ]dsxC{k s5: GYLPT&ZI\fdhw^{ )=?DNIY\lruyy t!-.5 8M#M>Zcgvlwy1 Wi+3IMNSg\Poy!M77F<>C NPUo%\'H,2@IMYelm`U!*p9?@mJCTPW"[\=aap-l13Z\f v{;(;>B\Jtz{ c$6*)>?m}{>>aW'2=lBUZaf~ w+G"<&(7;DQhh]i5w ".6]?DDEHi L(i,"FuLoM Ysx| T:$|%&;?EJju) 17^OV_2af|z .]9FtM_`bhhmj )!,{3:P=B@IPmy}f(+Y:J,J2LKMY;]9couwG{.?v?BC#RRPam d!")-.N:*BByDMPR.S{{uex#+`6mbpu~t"t`&;UnWmY,jmGo4pmppbr*((= >mDD2JKM)S[].{D"#D%,R1A#T#_mb#K678{IMV^bcimnMQ`+9038_;;hAFLT*X,Y\`]dfkm}LCDDJg@iKm8 %&15z7G-XqP|"Rc~ b?!%A&>@CVRWc2i"o%4NZrbitJ?$)2=< =>>Zf]er T FWq"$4.6TByZ0`~hqz{8}"  ;@DE7h=g>2BDNRhU[^c r8< >LTZ rwg#++8,/,0=C=JK R`Gk~"G$M)F49CDELOPo](^ _jp`u5LAZ\fkmz~w238_=bFQ[`e4ik{{|pN%"./E1R4NQ.pVpuvUzf| I2+0=>IXaMiPiECJF]F\r-:<1G0389~SYX^*pvtt"#/24ALdlw|[^}-.01W2Y^df\rz<6 ]8:E'XY|}~)e34@KA$BE]n^op|} &>(,..035=OY Zpk 6$>">'5-:ADEQ[[s ',NRjse%*,.1233O6q9? FH9\~lorF "%!:0<=F.M=QZt`Xluny}.),=EI_ 00G7Uapis} 'aQ%%7LO>]=b?!'7+;KVMWWhkk]m$v \9[9aKcKuxh~'oeBBJhQ\chY}] c$o*J9;8>}VhV||:`y2G5J]h(obKh4&BEJJ]gkUym|w"%(67BN:O\]D^uGU }l34 88cBDMIa=lu{rY3I5:^DqJ3MRVafgy1)9>;p ~[E 6#(3jEJnLTsXAZ~]{q|}Ts"-; ==QeLj5me%`L,O^e&gt vr5 +&o(-gH WbdIjwX##(*,X4C FHRjSgRmxmB ' **oMiX*]eFiPop{qm{ l%s004639O:<gSTUVa`@dhkzt:wx|~1,BI^brp Df.(*2D5]c@dtwz}uw {%3K==F QQRW\] \&->kmHs fi #2$4yAtEIb>fUf t-|Gb-J )+73M7WWY~kCW#$ FYGGThluxizH|.465U7Jj~k }. & -7f=,$H@K;f=f@nfx@UnknownG* Times New Roman5Symbol3. * Arial?. Arial Black5. *aTahoma;Wingdings?= * Courier NewA BCambria Math"1hf4gf4gqf*BV 4BV 4q4dff 3QHP ?2!xx"Sample Opioid Treatment AgreementsOpioids911-SafetyStewart B. Leavitt, MA, PhDBSDISx                      Oh+'0 $8 HT t   $Sample Opioid Treatment AgreementsOpioids911-SafetyStewart B. Leavitt, MA, PhD Normal.dotmBSDIS2Microsoft Office Word@| @~mD@=@= BV՜.+,D՜.+,P  hp|   4f #Sample Opioid Treatment Agreements Title 8@ _PID_HLINKSAP<*'/http://creativecommons.org/licenses/by-nc/3.0/=bhttp://pain-topics.org/ov8http://pain-topics.org/pdf/e-Briefing-Vol2-No2-2007.pdfz  Shttp://www.painedu.com/Downloads/tools/LowLiteracyMedicationManagementContract.pdfV Ehttp://www.aapainmanage.org/literature/Articles/OpioidAgreements.pdf Rhttp://health.utah.gov/prescription/pdf/guidelines/final.04.09opioidGuidlines.pdf/http://www.painedu.com/Downloads/AdditionalMaterials/Agreement_for_Opioid_Maintenance_Therapy_for_Non-Cancer_and_Cancer_Pain.pdfLBhttp://www.healthquality.va.gov/HEALTHQUALITY/cot/cot_310_sum.pdf*'/http://creativecommons.org/licenses/by-nc/3.0/Ahttp://opioids911.org/preview/content-images/creativecomlogo.png  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*,-./012456789:ARoot Entry F0qCData .1Table—WordDocumentڌSummaryInformation(+DocumentSummaryInformation83CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q